data_1o7b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o7b _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.627 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.417 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.64 ' HB3' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.582 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' T' ' 7' ' ' ALA . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.742 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.645 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.626 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.645 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.429 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.429 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.521 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.521 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.737 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.715 HG11 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.715 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.58 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.475 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.743 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.762 HG12 HG13 ' T' ' 76' ' ' ILE . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.52 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.586 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.762 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.795 HG23 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.795 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.742 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.582 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.58 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.504 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.551 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.626 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.716 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.442 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.406 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.772 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.519 ' HA3' HD21 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.489 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.449 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.619 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.619 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.733 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.3 t-80 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.603 HG21 ' O ' ' T' ' 45' ' ' HIS . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.606 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.614 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.427 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.569 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.67 ' HD2' HD13 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.733 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.694 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.694 ' HA2' ' H ' ' T' ' 65' ' ' GLY . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.774 HG23 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.774 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.772 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.512 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.587 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.519 HD21 ' HA3' ' T' ' 28' ' ' GLY . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.671 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.753 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.654 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.536 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.545 ' CZ ' ' HA3' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.564 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.564 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.636 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.5 t-80 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.679 HG11 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.553 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.679 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.55 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.505 ' O ' HD13 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.556 ' HE ' HD12 ' T' ' 80' ' ' ILE . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.685 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.805 HG12 HG13 ' T' ' 76' ' ' ILE . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.543 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.789 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.545 ' HA3' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.787 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.805 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.744 HG23 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.744 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' T' ' 85' ' ' SER . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.759 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.414 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.753 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.699 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.642 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.407 ' O ' HG21 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.639 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.662 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.447 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' T' ' 12' ' ' TYR . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.588 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.792 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.521 ' OE1' HG22 ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.599 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.711 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.711 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.547 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.547 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.51 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 15.0 t-160 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.541 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.673 ' HB1' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.639 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.598 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.673 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.51 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.552 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.707 HG21 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.707 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.565 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.55 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.598 ' NE1' HG23 ' T' ' 57' ' ' VAL . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.639 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.668 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.527 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.601 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.653 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.423 ' C ' HD13 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' T' ' 13' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' T' ' 7' ' ' ALA . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.7 ' HB2' HD22 ' T' ' 30' ' ' LEU . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.421 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.729 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' T' ' 19' ' ' ALA . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.744 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.419 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.419 ' CD ' HG22 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.433 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.525 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.525 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 3.0 t-80 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.594 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.557 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.507 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.694 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG3' ' HA3' ' T' ' 79' ' ' GLY . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.616 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.636 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.876 HG12 HG13 ' T' ' 76' ' ' ILE . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.54 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.679 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.876 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.64 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.445 HG23 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' T' ' 81' ' ' ARG . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.583 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.46 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.694 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.729 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.842 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.767 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.565 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.767 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.711 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.663 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.519 ' H ' ' HG1' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.67 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.631 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.535 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.535 ' OE1' HG21 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.583 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.583 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.419 ' HD2' ' CB ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.709 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.782 HG11 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.782 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.52 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.67 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.525 ' O ' HD13 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.558 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.703 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.587 ' HD2' HD13 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.787 HG12 HG13 ' T' ' 76' ' ' ILE . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.461 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' T' ' 68' ' ' CYS . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' T' ' 66' ' ' PRO . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.819 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.787 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.525 HD13 ' O ' ' T' ' 54' ' ' LYS . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.551 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.494 HD13 ' O ' ' T' ' 82' ' ' LEU . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.627 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.551 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.711 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.697 ' NE1' HG23 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.531 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.487 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.629 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.505 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.842 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.67 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.735 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.656 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.593 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.874 HD22 ' HA ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.633 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.59 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.675 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.532 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.694 ' HA3' HD21 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' T' ' 19' ' ' ALA . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HB2' ' T' ' 52' ' ' MET . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.655 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.655 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.676 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.463 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.656 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.459 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.537 ' CD1' HD13 ' T' ' 14' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.666 ' HA2' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.572 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.77 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.722 ' HD2' HD13 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.722 HD13 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.625 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.734 HG23 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.775 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.734 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.666 ' HD2' ' HA2' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.775 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.752 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.874 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.675 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.586 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.652 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.735 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.694 HD21 ' HA3' ' T' ' 28' ' ' GLY . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.719 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.632 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.749 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.788 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.779 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.73 ' HB2' HD23 ' T' ' 30' ' ' LEU . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.411 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' T' ' 23' ' ' CYS . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.401 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.73 HD23 ' HB2' ' T' ' 19' ' ' ALA . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.485 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.413 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.485 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.502 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.502 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 8.6 t-80 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.57 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.569 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.586 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.413 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.569 ' O ' HD13 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.52 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.702 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.689 HD13 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.577 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.677 HG23 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.677 ' H ' HG23 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.779 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.571 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.522 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.749 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.788 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.587 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' T' ' 2' ' ' VAL . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.614 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.687 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.475 ' HB1' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' T' ' 48' ' ' ALA . 23.6 ttpp . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.627 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.806 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG22 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.739 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' T' ' 30' ' ' LEU . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.529 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.46 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.529 ' OE1' HG21 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.673 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.673 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 9.5 t-80 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.481 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.627 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.619 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.627 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.533 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.429 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.61 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.803 HG23 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.557 HD22 ' HB3' ' T' ' 85' ' ' SER . 38.2 t30 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.557 ' HB3' HD22 ' T' ' 83' ' ' ASN . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.806 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.627 ' NE1' HG23 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.619 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.539 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.662 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.606 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.739 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.8 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.719 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.602 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.582 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.743 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.424 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.424 ' CD ' HG22 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.514 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.514 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.753 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.773 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.645 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.51 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.464 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.544 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.862 HG12 HG13 ' T' ' 76' ' ' ILE . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.519 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.474 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.862 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.51 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' T' ' 85' ' ' SER . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.464 ' H ' ' NE ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.568 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.659 ' O ' ' HG2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.707 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.54 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.607 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.836 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.743 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.613 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.635 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' T' ' 19' ' ' ALA . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' T' ' 15' ' ' THR . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.567 HG21 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.544 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.864 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.523 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.523 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.627 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.816 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.1 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.791 HG11 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.535 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.791 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.662 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.56 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.648 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.864 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.782 HG12 HG13 ' T' ' 76' ' ' ILE . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.816 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 73' ' ' THR . . . . . 0.526 HG21 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.54 ' HA3' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.813 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.782 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.662 HG23 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.662 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 41.5 t30 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.745 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.599 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.687 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' T' ' 90' ' ' ALA . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.784 ' HH ' ' HD2' ' T' ' 60' ' ' PRO . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.463 ' N ' ' O ' ' T' ' 3' ' ' TYR . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.76 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.482 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.688 ' NE2' ' HB3' ' T' ' 48' ' ' ALA . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.486 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.684 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' T' ' 88' ' ' TRP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.49 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.551 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' T' ' 23' ' ' CYS . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' T' ' 30' ' ' LEU . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.534 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.534 ' OE1' HG21 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.534 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.534 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.45 ' HD2' ' HB3' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.766 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 2.3 t-80 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.515 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.688 ' HB3' ' NE2' ' T' ' 4' ' ' HIS . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.717 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.526 ' O ' HD11 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.589 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.765 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.766 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.436 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.688 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.597 HG23 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.842 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.597 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.842 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.481 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.465 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.717 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' T' ' 4' ' ' HIS . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.587 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' T' ' 27' ' ' GLY . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.619 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.634 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.688 ' HB1' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.441 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.688 HD22 ' HB1' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.469 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.426 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.469 ' CD ' HG22 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.548 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.548 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.682 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.5 t-80 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.471 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' T' ' 4' ' ' HIS . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.741 ' CD2' HG22 ' T' ' 57' ' ' VAL . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.741 HG22 ' CD2' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.8 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.553 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.927 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.427 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.624 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.842 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.927 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.8 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' T' ' 85' ' ' SER . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.432 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.572 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.676 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.483 ' CB ' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.627 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.634 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.786 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.765 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.63 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.417 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.469 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.674 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.902 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.786 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.569 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.717 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.492 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.492 ' OE1' HG21 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.562 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.529 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.529 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.622 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.674 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.567 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.55 ' HA2' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.767 ' HD2' HD12 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.767 HD12 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.605 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.406 ' N ' HD13 ' T' ' 61' ' ' ILE . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.619 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.752 HG23 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.752 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.786 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.491 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.902 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.576 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.567 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.785 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.717 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.531 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.549 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.431 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.45 ' C ' ' H ' ' T' ' 25' ' ' PHE . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.689 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.54 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.484 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.484 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.598 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.6 t-160 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.685 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.577 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.685 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.582 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.563 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.711 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.598 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.503 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.6 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.55 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.821 HG23 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.821 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.717 HD22 ' HB3' ' T' ' 85' ' ' SER . 33.6 t30 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.642 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.717 ' HB3' HD22 ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.488 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.464 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.582 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.644 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.449 ' O ' HG21 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.655 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' T' ' 27' ' ' GLY . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.845 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.624 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.533 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.406 ' HB2' ' HG1' ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.631 ' HA3' HD22 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.514 HD12 ' O ' ' T' ' 51' ' ' TRP . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.735 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.564 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.434 ' CE1' HG22 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.564 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.656 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.656 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.592 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.673 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.797 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.522 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.514 ' O ' HD12 ' T' ' 30' ' ' LEU . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 56' ' ' ARG . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.528 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.739 ' HD2' HD12 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.739 HD12 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.455 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.752 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.666 HG23 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.666 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.718 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.686 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.586 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.48 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.629 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.573 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.845 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.631 HD22 ' HA3' ' T' ' 28' ' ' GLY . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.661 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.677 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.601 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.899 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.844 HD22 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.547 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.549 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.486 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' T' ' 19' ' ' ALA . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.492 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.56 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.533 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 11.0 t-160 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.521 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.549 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.521 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.54 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.486 ' HE2' ' OD2' ' T' ' 77' ' ' ASP . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.518 ' O ' HD13 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.469 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.585 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.566 ' O ' HD12 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.802 HG12 HG13 ' T' ' 76' ' ' ILE . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' T' ' 68' ' ' CYS . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.413 ' H ' ' C ' ' T' ' 66' ' ' PRO . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.802 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.486 ' OD2' ' HE2' ' T' ' 52' ' ' MET . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.79 HG23 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.79 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.529 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.899 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.718 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.844 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.687 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.677 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.607 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' T' ' 94' ' ' ASN . 81.7 t60 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.802 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.802 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.517 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.748 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.598 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.58 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.679 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.534 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' T' ' 19' ' ' ALA . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.506 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.506 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.495 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.494 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.494 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.768 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 1.5 t-80 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.529 HG21 ' C ' ' T' ' 45' ' ' HIS . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' T' ' 46' ' ' VAL . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.697 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.542 ' O ' HD13 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.598 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.603 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.584 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.784 ' HD2' HD13 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.784 HD13 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.532 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.503 ' HB3' ' HA2' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.443 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.443 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 4.3 p30 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . 0.62 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.569 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.672 HG23 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.597 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.672 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.597 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.748 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.697 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.866 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.485 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.51 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.624 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.704 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.679 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.649 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.496 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.827 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.88 HD22 ' HA ' ' T' ' 89' ' ' ASP . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' T' ' 14' ' ' LEU . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.669 ' HB2' HD22 ' T' ' 30' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.411 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' T' ' 23' ' ' CYS . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' T' ' 19' ' ' ALA . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.438 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.485 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.438 ' CD ' HG22 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.409 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.551 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.551 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' T' ' 61' ' ' ILE . 17.0 t-160 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.487 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.586 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.674 ' HB1' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.643 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.485 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.6 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.702 ' HB2' HD12 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.755 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.905 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.429 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HA3' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.554 ' SG ' HG22 ' T' ' 61' ' ' ILE . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.755 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.905 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.709 HG23 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.709 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' T' ' 85' ' ' SER . 39.5 t30 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.536 ' HB2' HD22 ' T' ' 83' ' ' ASN . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.42 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.827 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.724 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.88 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.533 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.656 ' HH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.743 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' T' ' 96' ' ' HIS . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.837 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.65 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.67 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.67 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.514 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.744 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' T' ' 23' ' ' CYS . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.592 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.502 HD12 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.494 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.425 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.494 ' OE1' HG21 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.616 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.616 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.569 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.8 t-160 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.538 HG12 ' OH ' ' T' ' 91' ' ' TYR . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.545 ' HB1' ' NE2' ' T' ' 4' ' ' HIS . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.635 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.425 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.403 ' HD3' ' OD2' ' T' ' 77' ' ' ASP . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.606 ' HD2' HD12 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.645 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.553 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 66' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 67' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 70' ' ' PHE . . . . . 0.411 ' HB2' HD13 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.543 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.403 ' OD2' ' HD3' ' T' ' 56' ' ' ARG . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.497 HG23 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.497 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.652 HD22 ' HB3' ' T' ' 85' ' ' SER . 40.3 t30 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.652 ' HB3' HD22 ' T' ' 83' ' ' ASN . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.446 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.744 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.779 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.847 ' HA ' HD22 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.706 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.678 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.672 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.837 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.592 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 95' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.627 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.417 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.64 ' HB3' HD22 ' T' ' 14' ' ' LEU . . . -64.23 -170.87 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -47.39 -31.88 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.799 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.37 -19.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.7 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.32 159.85 23.54 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm -113.22 155.58 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.582 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' T' ' 7' ' ' ALA . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.742 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.645 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' T' ' 97' ' ' ALA . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.626 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.645 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.429 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.429 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.521 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.521 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.737 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.715 HG11 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.715 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.58 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.475 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.717 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.743 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.762 HG12 HG13 ' T' ' 76' ' ' ILE . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.52 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.586 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.762 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.795 HG23 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.795 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.742 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.582 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.58 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.504 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.551 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.626 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' T' ' 97' ' ' ALA . 1.7 m-70 -131.43 -45.84 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' T' ' 27' ' ' GLY . . . 33.26 53.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.26 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 tttp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.938 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.716 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.442 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . -61.45 -174.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -30.19 1.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -168.72 -16.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.3 161.42 25.28 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.406 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER -113.44 152.96 29.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.772 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.519 ' HA3' HD21 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.489 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.449 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.4 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.619 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.619 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.733 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.3 t-80 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.603 HG21 ' O ' ' T' ' 45' ' ' HIS . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.606 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.614 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.427 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.569 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.67 ' HD2' HD13 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.733 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.694 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.694 ' HA2' ' H ' ' T' ' 65' ' ' GLY . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.774 HG23 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.774 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.772 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.605 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.512 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.587 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -110.5 7.7 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -83.85 50.18 1.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.671 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' T' ' 14' ' ' LEU . . . -73.09 -170.91 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.36 -42.48 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -169.3 23.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.484 ' HA2' ' HD3' ' T' ' 13' ' ' LYS . . . -122.81 166.9 15.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.412 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -112.94 148.8 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.753 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.759 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.654 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.536 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.545 ' CZ ' ' HA3' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.564 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.564 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.636 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.5 t-80 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.679 HG11 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.553 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.679 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.55 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.505 ' O ' HD13 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.556 ' HE ' HD12 ' T' ' 80' ' ' ILE . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.643 HG23 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.685 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.805 HG12 HG13 ' T' ' 76' ' ' ILE . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.543 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.789 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.545 ' HA3' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.787 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.805 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.744 HG23 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.744 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' T' ' 85' ' ' SER . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.759 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.414 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.753 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.699 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.642 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.407 ' O ' HG21 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.639 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.433 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 -102.21 13.27 35.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -85.83 44.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.944 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.662 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.447 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' T' ' 12' ' ' TYR . . . -60.26 -170.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -37.68 20.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -163.63 1.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.86 12.25 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.32 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 127.78 32.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.588 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.792 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.521 ' OE1' HG22 ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.599 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.711 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.711 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.547 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.547 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.51 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 15.0 t-160 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.541 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.673 ' HB1' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.639 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.5 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.598 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.673 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.51 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.552 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.707 HG21 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.565 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.707 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.565 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.792 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.55 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.598 ' NE1' HG23 ' T' ' 57' ' ' VAL . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.639 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.668 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.527 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.821 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -115.3 5.06 14.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -81.58 51.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.653 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.423 ' C ' HD13 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' T' ' 13' ' ' LYS . . . -72.44 -169.94 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -55.84 -26.77 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -174.28 46.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.99 168.43 38.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -107.55 158.56 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' T' ' 7' ' ' ALA . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.7 ' HB2' HD22 ' T' ' 30' ' ' LEU . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.421 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.729 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' T' ' 19' ' ' ALA . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.744 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.419 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.419 ' CD ' HG22 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.433 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.525 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.525 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 3.0 t-80 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.594 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.557 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.507 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.694 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG3' ' HA3' ' T' ' 79' ' ' GLY . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.616 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.636 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.876 HG12 HG13 ' T' ' 76' ' ' ILE . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.54 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.679 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.876 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.64 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.445 HG23 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' T' ' 81' ' ' ARG . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.583 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.46 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.694 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.729 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -117.24 0.42 12.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -81.92 48.44 1.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.87 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.842 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.767 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.565 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -85.3 159.59 20.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -28.93 65.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -14.67 45.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.87 167.88 16.7 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.347 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.767 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? -83.39 153.2 24.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.711 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.663 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.519 ' H ' ' HG1' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.67 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.631 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.535 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.535 ' OE1' HG21 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.583 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.583 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.419 ' HD2' ' CB ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.709 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.782 HG11 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.451 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.782 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.52 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.67 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.525 ' O ' HD13 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.558 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.703 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.587 ' HD2' HD13 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.819 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.787 HG12 HG13 ' T' ' 76' ' ' ILE . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.461 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' T' ' 68' ' ' CYS . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.463 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' T' ' 66' ' ' PRO . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.819 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.787 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.525 HD13 ' O ' ' T' ' 54' ' ' LYS . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.551 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.494 HD13 ' O ' ' T' ' 82' ' ' LEU . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.627 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.551 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.711 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.697 ' NE1' HG23 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.531 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.487 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.629 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.505 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.842 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.67 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -130.31 15.83 5.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.85 52.0 2.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.878 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.735 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.27 151.64 24.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -66.48 -7.04 17.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.45 -27.87 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.97 172.52 19.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -58.14 131.01 49.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.656 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.593 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.874 HD22 ' HA ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.633 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.59 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.675 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.532 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.694 ' HA3' HD21 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' T' ' 19' ' ' ALA . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HB2' ' T' ' 52' ' ' MET . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.655 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.655 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.676 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.463 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.656 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.77 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.459 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.537 ' CD1' HD13 ' T' ' 14' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.423 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.666 ' HA2' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.572 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.77 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.722 ' HD2' HD13 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.722 HD13 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.625 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.734 HG23 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.775 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.734 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.666 ' HD2' ' HA2' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.775 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.752 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.874 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.675 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.586 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.652 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.735 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.788 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -112.29 11.77 20.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.788 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -84.86 47.63 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.719 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.632 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -84.91 162.52 19.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.5 67.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.473 ' HB2' ' HZ3' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -93.0 -49.05 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.22 -173.52 32.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp -101.22 155.52 17.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.749 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.788 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.779 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.73 ' HB2' HD23 ' T' ' 30' ' ' LEU . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.411 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' T' ' 23' ' ' CYS . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.401 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.73 HD23 ' HB2' ' T' ' 19' ' ' ALA . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.485 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.413 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.485 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.502 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.502 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 8.6 t-80 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.57 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.569 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.472 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.586 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.413 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.569 ' O ' HD13 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.52 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.702 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.689 HD13 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.577 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.677 HG23 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.677 ' H ' HG23 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.779 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.571 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.522 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.749 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.788 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.587 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' T' ' 2' ' ' VAL . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.614 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.687 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -117.62 -10.04 10.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -83.01 55.38 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.475 ' HB1' HD22 ' T' ' 14' ' ' LEU . . . -86.37 160.59 19.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' T' ' 8' ' ' ARG . 16.7 mtm180 -65.15 -14.52 60.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 -29.46 11.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.38 173.27 30.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.421 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' T' ' 48' ' ' ALA . 23.6 ttpp -80.91 152.95 27.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.627 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.806 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG22 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.739 ' HA3' ' CG ' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' T' ' 30' ' ' LEU . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.529 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.46 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.529 ' OE1' HG21 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.673 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.673 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 9.5 t-80 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.481 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.627 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.695 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.619 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.627 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.695 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.533 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.429 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.61 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.803 HG23 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.557 HD22 ' HB3' ' T' ' 85' ' ' SER . 38.2 t30 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.557 ' HB3' HD22 ' T' ' 83' ' ' ASN . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.806 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.627 ' NE1' HG23 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.619 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.539 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.662 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.606 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.739 ' CG ' ' HA3' ' T' ' 28' ' ' GLY . 0.8 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -116.23 -14.9 11.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.57 56.58 4.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.048 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.888 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.719 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.602 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -83.69 152.98 24.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -67.06 -15.93 64.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 93.7 p -96.13 -17.57 20.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.67 173.91 25.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.281 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? -58.92 146.81 36.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.582 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' T' ' 97' ' ' ALA . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.743 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.424 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.424 ' CD ' HG22 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.514 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.514 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.753 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.773 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.645 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.51 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.464 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.544 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.862 HG12 HG13 ' T' ' 76' ' ' ILE . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.519 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.474 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.862 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.51 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . . . . . . . . . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' T' ' 85' ' ' SER . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.464 ' H ' ' NE ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.568 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.659 ' O ' ' HG2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.707 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.54 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.607 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.836 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.743 ' HB2' ' HA3' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -118.51 -6.66 10.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -80.02 55.44 2.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.613 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.635 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.14 155.74 18.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -16.39 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.6 p -97.49 -16.66 20.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.65 172.6 21.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.277 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm -58.4 148.13 28.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' T' ' 19' ' ' ALA . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' T' ' 15' ' ' THR . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.567 HG21 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.544 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.864 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.523 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.523 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.627 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.816 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.1 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.791 HG11 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.535 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.791 ' H ' HG11 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.662 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.56 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.648 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.864 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.782 HG12 HG13 ' T' ' 76' ' ' ILE . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.816 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 73' ' ' THR . . . . . 0.526 HG21 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.54 ' HA3' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.813 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.782 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.662 HG23 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.662 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 41.5 t30 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.745 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.599 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.687 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' T' ' 90' ' ' ALA . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.784 ' HH ' ' HD2' ' T' ' 60' ' ' PRO . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.463 ' N ' ' O ' ' T' ' 3' ' ' TYR . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.76 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -101.04 6.11 43.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -81.43 46.69 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.688 ' NE2' ' HB3' ' T' ' 48' ' ' ALA . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.486 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.63 164.23 11.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -20.19 53.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.0 -47.31 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.5 -168.33 41.37 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.341 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.486 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt -66.18 139.61 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.684 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' T' ' 88' ' ' TRP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.49 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.551 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' T' ' 23' ' ' CYS . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' T' ' 30' ' ' LEU . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.534 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.534 ' OE1' HG21 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.534 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.534 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.45 ' HD2' ' HB3' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.766 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 2.3 t-80 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.515 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.688 ' HB3' ' NE2' ' T' ' 4' ' ' HIS . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.717 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.526 ' O ' HD11 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.55 ' HA ' HD12 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.589 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.765 ' HD2' HD12 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.766 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.436 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.688 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.597 HG23 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.842 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.597 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.842 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.481 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.465 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.717 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.623 ' HA ' HD23 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' T' ' 4' ' ' HIS . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.587 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.723 ' HB3' ' HB1' ' T' ' 97' ' ' ALA . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.17 6.79 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.723 ' HB1' ' HB3' ' T' ' 94' ' ' ASN . . . -85.67 55.83 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.619 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.634 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.688 ' HB1' HD22 ' T' ' 14' ' ' LEU . . . -79.81 145.69 32.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -52.11 -23.76 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -48.6 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -178.01 39.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.693 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt -90.03 156.05 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.441 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.688 HD22 ' HB1' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.469 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.426 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.469 ' CD ' HG22 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.548 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.548 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.682 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.5 t-80 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.471 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' T' ' 4' ' ' HIS . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.741 ' CD2' HG22 ' T' ' 57' ' ' VAL . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.575 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.741 HG22 ' CD2' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.8 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.553 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.927 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.427 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.624 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.842 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.927 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.8 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' T' ' 85' ' ' SER . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.432 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.572 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.676 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.483 ' CB ' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.627 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.634 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.786 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.8 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -121.1 8.74 10.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.8 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -84.6 48.06 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.63 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.417 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.469 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . -60.71 -176.35 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -45.99 -40.59 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 87.1 p -157.45 -5.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.28 163.64 14.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.277 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -109.98 145.1 37.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.674 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.902 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.786 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.569 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.717 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.492 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.492 ' OE1' HG21 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.562 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.529 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.529 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.622 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.674 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.567 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.55 ' HA2' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.767 ' HD2' HD12 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.767 HD12 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.605 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.406 ' N ' HD13 ' T' ' 61' ' ' ILE . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.619 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.533 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.752 HG23 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.752 ' H ' HG23 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.786 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.491 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.902 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.576 ' CE3' ' HB2' ' T' ' 49' ' ' ALA . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.567 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.478 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.785 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.909 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -119.64 -6.9 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.909 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -80.02 55.04 2.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.531 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.549 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' T' ' 14' ' ' LEU . . . -67.16 -175.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -55.46 -33.47 63.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.61 49.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.51 164.33 29.82 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.414 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER -109.17 161.75 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.431 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.45 ' C ' ' H ' ' T' ' 25' ' ' PHE . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.689 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.689 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.54 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.484 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.484 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.598 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.6 t-160 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.685 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.577 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.685 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.582 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.563 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.711 ' HD1' ' HB1' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.598 ' HA ' ' HD2' ' T' ' 45' ' ' HIS . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.503 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.6 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.55 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.821 HG23 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.821 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.717 HD22 ' HB3' ' T' ' 85' ' ' SER . 33.6 t30 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.642 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.717 ' HB3' HD22 ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.488 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.464 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.582 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.644 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.449 ' O ' HG21 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.655 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.705 ' HB3' ' HB1' ' T' ' 97' ' ' ALA . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -115.67 -8.87 12.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.705 ' HB1' ' HB3' ' T' ' 94' ' ' ASN . . . -82.38 55.94 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.845 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.624 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -78.08 -172.4 2.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . 0.48 HH11 ' HB2' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -51.54 -36.87 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.8 7.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.02 164.96 12.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.43 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -106.21 142.12 36.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.533 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.406 ' HB2' ' HG1' ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.48 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.631 ' HA3' HD22 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.514 HD12 ' O ' ' T' ' 51' ' ' TRP . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.735 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.564 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.434 ' CE1' HG22 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.564 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.656 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.656 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.592 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.673 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.797 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.522 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.514 ' O ' HD12 ' T' ' 30' ' ' LEU . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 56' ' ' ARG . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.528 HG23 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.739 ' HD2' HD12 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.739 HD12 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.455 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.752 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.666 HG23 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.666 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.718 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.686 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.586 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.48 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.629 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.573 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.845 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.744 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -122.77 16.7 10.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.744 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . -79.25 47.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.661 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.677 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.601 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -66.02 -168.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -46.35 -38.87 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.16 -14.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.2 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.71 163.0 12.35 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.341 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER -113.83 152.74 30.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.899 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.844 HD22 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.547 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.549 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.486 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' T' ' 19' ' ' ALA . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.492 ' HG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' HG1' ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.56 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.533 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 11.0 t-160 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.521 HG21 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.549 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.521 ' H ' HG21 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.54 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.486 ' HE2' ' OD2' ' T' ' 77' ' ' ASP . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.518 ' O ' HD13 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.469 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.585 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.566 ' O ' HD12 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.802 HG12 HG13 ' T' ' 76' ' ' ILE . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' T' ' 68' ' ' CYS . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.413 ' H ' ' C ' ' T' ' 66' ' ' PRO . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.802 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.486 ' OD2' ' HE2' ' T' ' 52' ' ' MET . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.79 HG23 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.79 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.529 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.899 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.718 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.844 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.687 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.677 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' T' ' 97' ' ' ALA . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' T' ' 94' ' ' ASN . 81.7 t60 -123.0 -8.31 8.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' T' ' 94' ' ' ASN . . . -80.05 54.33 1.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.802 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' T' ' 14' ' ' LEU . . . -89.19 163.81 15.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.51 72.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -85.15 -15.94 42.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.995 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.25 169.35 14.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.322 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.802 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt -75.7 146.91 39.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.517 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.748 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.598 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.58 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' T' ' 15' ' ' THR . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.679 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.534 ' N ' ' CD2' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' T' ' 19' ' ' ALA . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.506 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.506 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.495 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.494 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.494 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.768 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 1.5 t-80 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.529 HG21 ' C ' ' T' ' 45' ' ' HIS . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' T' ' 46' ' ' VAL . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.697 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.542 ' O ' HD13 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.598 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.603 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.584 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.784 ' HD2' HD13 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.784 HD13 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.532 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.503 ' HB3' ' HA2' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.443 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.443 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 4.3 p30 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.62 ' HA3' HG23 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.569 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.672 HG23 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.597 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.672 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.597 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.748 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.697 ' HB2' ' NE1' ' T' ' 51' ' ' TRP . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.866 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.485 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.51 ' O ' ' HB1' ' T' ' 31' ' ' ALA . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.624 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.704 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.679 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -117.54 -11.14 10.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.9 53.97 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.649 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . -66.27 -169.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -26.33 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.7 t -172.38 47.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' T' ' 6' ' ' GLU . . . 174.63 166.6 32.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.387 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.496 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt -103.37 143.81 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.827 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.88 HD22 ' HA ' ' T' ' 89' ' ' ASP . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' T' ' 14' ' ' LEU . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.669 ' HB2' HD22 ' T' ' 30' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.411 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' T' ' 23' ' ' CYS . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' T' ' 19' ' ' ALA . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.438 HG22 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.485 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.438 ' CD ' HG22 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.409 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.551 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.551 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' T' ' 61' ' ' ILE . 17.0 t-160 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.487 HG12 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.586 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.674 ' HB1' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.643 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.485 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.6 HG23 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.702 ' HB2' HD12 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.755 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.905 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.429 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.439 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HA3' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.554 ' SG ' HG22 ' T' ' 61' ' ' ILE . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.755 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.905 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.709 HG23 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.709 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' T' ' 85' ' ' SER . 39.5 t30 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.536 ' HB2' HD22 ' T' ' 83' ' ' ASN . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.42 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.827 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.724 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.88 ' HA ' HD22 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.533 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.656 ' HH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.743 ' HB2' ' HB3' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.698 ' HB3' ' HB1' ' T' ' 97' ' ' ALA . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER -133.49 6.9 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' T' ' 94' ' ' ASN . . . -82.88 51.49 1.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.959 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.837 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.65 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.67 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -93.69 153.29 18.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -21.19 66.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -88.1 -16.6 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.51 168.4 15.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.349 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.67 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? -92.73 147.54 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.514 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.744 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' T' ' 19' ' ' ALA . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.706 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' T' ' 25' ' ' PHE . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' T' ' 23' ' ' CYS . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.592 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.502 HD12 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.494 HG21 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.425 ' HD1' ' HE2' ' T' ' 52' ' ' MET . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.494 ' OE1' HG21 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.616 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.616 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.569 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.8 t-160 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.538 HG12 ' OH ' ' T' ' 91' ' ' TYR . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.545 ' HB1' ' NE2' ' T' ' 4' ' ' HIS . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.7 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.635 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.425 ' HE2' ' HD1' ' T' ' 33' ' ' TYR . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.403 ' HD3' ' OD2' ' T' ' 77' ' ' ASP . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.606 ' HD2' HD12 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.645 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.553 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . 0.411 ' HB2' HD13 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.543 ' O ' ' HA3' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.403 ' OD2' ' HD3' ' T' ' 56' ' ' ARG . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.497 HG23 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.497 ' H ' HG23 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.652 HD22 ' HB3' ' T' ' 85' ' ' SER . 40.3 t30 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.606 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.652 ' HB3' HD22 ' T' ' 83' ' ' ASN . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.446 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.744 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.779 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.847 ' HA ' HD22 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.706 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.678 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.672 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.837 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.831 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -126.03 24.4 6.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.831 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . -81.78 48.31 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.962 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.636 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' T' ' 5' ' ' ARG . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.665 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.639 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.665 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.627 HD22 ' O ' ' T' ' 51' ' ' TRP . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.495 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' T' ' 36' ' ' LEU . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.545 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.545 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.2 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.758 HG12 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.758 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.745 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.627 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.705 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.742 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.785 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.858 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.858 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.705 ' NE1' HG21 ' T' ' 57' ' ' VAL . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.575 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.51 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.529 ' O ' HG23 ' T' ' 2' ' ' VAL . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.69 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.639 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.425 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.415 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.542 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.582 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.402 ' CE1' HG21 ' T' ' 75' ' ' ILE . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.582 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.624 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.624 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' T' ' 39' ' ' ALA . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.602 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 5.1 t60 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.673 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.851 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.611 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.447 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.735 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.913 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.913 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.711 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.846 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.529 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' T' ' 86' ' ' GLU . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.778 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.735 ' NE1' HG21 ' T' ' 57' ' ' VAL . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.611 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.542 HD22 ' HA2' ' T' ' 28' ' ' GLY . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.678 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' T' ' 89' ' ' ASP . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.763 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.422 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.772 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.422 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.658 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.664 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.55 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' T' ' 75' ' ' ILE . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.55 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.56 ' CZ ' ' HA2' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.559 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.559 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 45' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.672 HG12 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.558 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.672 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.861 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.7 ' O ' HD22 ' T' ' 30' ' ' LEU . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.568 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.575 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.568 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.717 HG21 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.938 HG21 ' HA2' ' T' ' 69' ' ' GLY . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.938 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.785 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.832 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.786 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.786 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.452 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.763 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' T' ' 57' ' ' VAL . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.654 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.598 ' O ' HG23 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.664 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 96' ' ' HIS . . . . . 0.431 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.469 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.596 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.773 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.463 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.826 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.463 ' HB2' ' H ' ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.409 ' C ' HD22 ' T' ' 94' ' ' ASN . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.62 HD22 ' O ' ' T' ' 51' ' ' TRP . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.517 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.517 ' OE1' HG23 ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.538 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' T' ' 61' ' ' ILE . 6.3 t60 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.591 HG22 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.758 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.518 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.413 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.539 ' HA ' HD13 ' T' ' 80' ' ' ILE . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.645 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.758 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.572 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.822 HG22 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.822 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' T' ' 81' ' ' ARG . 1.8 m-20 -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.826 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.524 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.658 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.808 ' HA ' HD12 ' T' ' 14' ' ' LEU . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.756 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.63 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.423 ' O ' HD11 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.53 HG23 ' OE1' ' T' ' 18' ' ' GLU . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.53 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 26' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' T' ' 5' ' ' ARG . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.796 ' HA2' ' ND2' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.534 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.541 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.541 ' CD ' HG23 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' T' ' 36' ' ' LEU . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.519 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.519 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 4.8 t60 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.603 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.583 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.849 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.708 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.537 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.817 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 68' ' ' CYS . . . . . 0.494 ' SG ' ' HE1' ' T' ' 45' ' ' HIS . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.869 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.894 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.671 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.535 ' HA2' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.594 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.594 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.614 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.429 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.817 ' NE1' HG21 ' T' ' 57' ' ' VAL . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.606 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.603 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.521 ' O ' HG23 ' T' ' 2' ' ' VAL . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.796 ' ND2' ' HA2' ' T' ' 28' ' ' GLY . 0.2 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.85 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.772 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.733 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.71 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.644 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.577 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.531 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.509 ' CE1' HG21 ' T' ' 75' ' ' ILE . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' T' ' 75' ' ' ILE . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.578 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.497 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.801 HG12 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.801 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.741 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.682 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.617 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.795 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.837 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.837 HD11 ' HD2' ' T' ' 59' ' ' TYR . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.466 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 66' ' ' PRO . . . . . 0.533 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 68' ' ' CYS . . . . . 0.489 ' SG ' HG23 ' T' ' 61' ' ' ILE . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.81 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.554 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.588 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.554 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.795 ' NE1' HG21 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.527 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.639 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.761 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.85 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.677 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.869 HD11 ' O ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.664 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.459 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.664 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.86 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.537 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.562 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.607 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.607 ' CD ' HG23 ' T' ' 32' ' ' THR . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' T' ' 40' ' ' ARG . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.3 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.672 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.467 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.666 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.562 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.708 ' HA3' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.686 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.978 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 68' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.648 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.787 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.779 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.708 ' HD2' ' HA3' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.787 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.615 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.869 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' HG13 ' T' ' 46' ' ' VAL . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.654 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.734 HD22 ' HA2' ' T' ' 28' ' ' GLY . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.407 ' HD3' HH11 ' T' ' 5' ' ' ARG . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.736 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.564 HG23 ' OE1' ' T' ' 18' ' ' GLU . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.564 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.584 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.7 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.666 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.486 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.486 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.645 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.528 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.528 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.481 ' HE1' HG23 ' T' ' 61' ' ' ILE . 16.7 t60 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.484 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.969 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.666 ' O ' HD22 ' T' ' 30' ' ' LEU . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.407 ' O ' ' HE1' ' T' ' 16' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.549 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.969 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.797 HD11 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 68' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' T' ' 36' ' ' LEU . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.901 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.901 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.811 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.538 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.801 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.597 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.623 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.7 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.606 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.864 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 23.6 ttpp . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.645 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.813 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.864 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.469 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.752 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.469 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.404 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.791 ' HA2' ' ND2' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.663 HD22 ' O ' ' T' ' 51' ' ' TRP . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.74 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.548 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.49 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.548 ' OE1' HG23 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.684 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.684 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.517 ' HE1' HG23 ' T' ' 61' ' ' ILE . 22.5 t60 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.482 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.645 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.663 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.779 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.86 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.671 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.86 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.632 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.861 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.861 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.813 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.779 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.671 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.791 ' ND2' ' HA2' ' T' ' 28' ' ' GLY . 0.2 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.727 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.562 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.474 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.474 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.773 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.703 HD22 ' O ' ' T' ' 51' ' ' TRP . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.58 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.58 ' OE1' HG23 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.538 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.554 ' HB2' HG23 ' T' ' 62' ' ' VAL . 1.5 t60 -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.615 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.665 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.786 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.703 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.899 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.899 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 66' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.887 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.576 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.513 ' NE ' ' H ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.535 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.769 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.713 ' HA ' HD12 ' T' ' 14' ' ' LEU . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.779 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.773 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.62 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.657 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.626 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' T' ' 89' ' ' ASP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.57 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.709 HD22 ' O ' ' T' ' 51' ' ' TRP . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.632 HG23 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.632 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' T' ' 91' ' ' TYR . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.885 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.522 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.522 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.831 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.8 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.891 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.891 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.709 ' O ' HD22 ' T' ' 30' ' ' LEU . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.738 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.885 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.925 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.843 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 73' ' ' THR . . . . . 0.573 HG22 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.552 ' HA2' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.793 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.746 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.746 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.754 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.738 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.71 ' HA ' HD12 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.665 ' CB ' HD21 ' T' ' 36' ' ' LEU . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG23 ' T' ' 2' ' ' VAL . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.488 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.579 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.701 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.856 HD11 ' O ' ' T' ' 89' ' ' ASP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.624 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.461 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' T' ' 30' ' ' LEU . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.646 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.523 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.646 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.558 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.548 ' HD2' ' HB1' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' HG23 ' T' ' 62' ' ' VAL . 4.4 t60 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.579 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.518 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.701 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.725 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.545 ' O ' HD12 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.54 ' HA ' HD13 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.682 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.856 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.856 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' T' ' 69' ' ' GLY . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.712 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.833 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.869 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.833 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.869 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.426 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.618 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.741 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.856 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.579 ' OH ' HG13 ' T' ' 46' ' ' VAL . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' T' ' 95' ' ' PRO . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.703 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.732 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.423 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.732 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.492 HG23 ' OE1' ' T' ' 18' ' ' GLU . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.795 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.671 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.621 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' T' ' 75' ' ' ILE . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.662 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.574 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 7.1 t60 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB1' HG13 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.671 ' O ' HD22 ' T' ' 30' ' ' LEU . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.591 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.485 ' C ' HD12 ' T' ' 80' ' ' ILE . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.828 HG13 ' HB1' ' T' ' 49' ' ' ALA . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.832 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.853 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.954 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.656 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.412 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.86 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.824 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.954 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.641 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.641 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.436 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.536 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.62 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.682 ' CD1' HG11 ' T' ' 57' ' ' VAL . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.795 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.638 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.925 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.638 HD21 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.439 HG23 ' OE1' ' T' ' 18' ' ' GLU . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.817 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.422 ' C ' HD22 ' T' ' 94' ' ' ASN . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.746 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' T' ' 51' ' ' TRP . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.482 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' T' ' 75' ' ' ILE . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.482 ' CD ' HG23 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.573 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.527 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.527 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.412 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.761 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.625 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.568 ' HA3' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.675 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.77 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.623 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.549 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.82 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.82 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.817 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.446 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.925 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.675 ' NE1' HG21 ' T' ' 57' ' ' VAL . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.56 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.665 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.543 ' O ' HG23 ' T' ' 2' ' ' VAL . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.746 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.569 HG23 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.597 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.484 HG23 ' OE1' ' T' ' 18' ' ' GLU . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.484 ' OE1' HG23 ' T' ' 15' ' ' THR . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' T' ' 30' ' ' LEU . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.418 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.688 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.698 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.698 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.521 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.478 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.478 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.542 ' HE1' HG23 ' T' ' 61' ' ' ILE . 8.8 t60 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.642 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.642 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.896 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.688 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.412 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.716 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.74 ' HG3' HD12 ' T' ' 36' ' ' LEU . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.622 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 66' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' T' ' 36' ' ' LEU . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.866 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.866 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' T' ' 85' ' ' SER . 9.3 t-20 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.67 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.511 ' H ' ' C ' ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.716 ' NE1' HG21 ' T' ' 57' ' ' VAL . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.578 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.613 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.569 ' O ' HG23 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.42 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.625 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.412 HG23 ' OE1' ' T' ' 18' ' ' GLU . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' T' ' 22' ' ' VAL . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.649 ' HA2' HD21 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.611 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.611 ' CD ' HG23 ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.464 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.669 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.669 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.495 ' CG ' ' H ' ' T' ' 62' ' ' VAL . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.722 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.722 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.421 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.658 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.709 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.709 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.53 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.725 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.697 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.682 ' OH ' HG13 ' T' ' 46' ' ' VAL . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.851 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.649 HD21 ' HA2' ' T' ' 28' ' ' GLY . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.923 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.941 HD21 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.647 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.5 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.587 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.516 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.525 ' HD1' ' HE1' ' T' ' 52' ' ' MET . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.516 ' CD ' HG23 ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.716 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.679 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.679 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 7.2 t60 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.57 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.57 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.587 ' O ' HD22 ' T' ' 30' ' ' LEU . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.525 ' HE1' ' HD1' ' T' ' 33' ' ' TYR . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.502 ' O ' HD12 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.494 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' T' ' 73' ' ' THR . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' T' ' 66' ' ' PRO . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 66' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' T' ' 65' ' ' GLY . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 73' ' ' THR . . . . . 0.404 HG22 ' HG3' ' T' ' 64' ' ' PRO . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' T' ' 36' ' ' LEU . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.865 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.865 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.487 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.723 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.941 ' HA ' HD21 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.698 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.68 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.637 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.816 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.521 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.781 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.918 HD11 ' O ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.667 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.688 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.456 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.697 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.526 HD22 ' O ' ' T' ' 51' ' ' TRP . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.54 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.54 ' CD ' HG23 ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.491 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.491 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.535 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.9 t60 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.401 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' HE2' ' T' ' 11' ' ' LYS . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.499 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.691 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 63' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HB3' ' HA3' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 69' ' ' GLY . . . . . 0.763 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.591 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.411 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.706 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.706 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.781 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.918 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' T' ' 36' ' ' LEU . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.643 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.697 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.51 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.4 ' CZ ' ' HZ3' ' T' ' 88' ' ' TRP . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.834 ' CD1' ' HB2' ' T' ' 19' ' ' ALA . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.615 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' T' ' 15' ' ' THR . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.478 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.596 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.596 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.602 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.449 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.543 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.543 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.691 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.9 t60 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.527 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.537 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.858 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.655 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.693 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.858 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.937 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.713 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 71' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.753 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.937 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.769 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.769 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.412 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.856 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.777 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.831 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.582 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' T' ' 96' ' ' HIS . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 96' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.647 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.776 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.687 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.687 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' T' ' 7' ' ' ALA . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.604 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.516 HD13 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.589 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.444 ' CE1' HG21 ' T' ' 75' ' ' ILE . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.589 ' OE1' HG23 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.411 ' HA ' ' H ' ' T' ' 44' ' ' PHE . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.62 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.62 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.506 ' HE1' HG23 ' T' ' 61' ' ' ILE . 11.7 t60 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.803 HG22 ' H ' ' T' ' 48' ' ' ALA . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.651 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.803 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.646 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.47 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.849 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.849 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.429 ' C ' ' HD3' ' T' ' 64' ' ' PRO . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 66' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 67' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 68' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 70' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.936 HG22 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.936 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 11.5 t-20 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.632 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.776 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.785 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.872 ' HA ' HD21 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.684 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.689 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.604 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 95' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.636 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' T' ' 5' ' ' ARG . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -64.23 -170.87 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -47.39 -31.88 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.799 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.37 -19.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.7 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.32 159.85 23.54 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm -113.22 155.58 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.665 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' T' ' 97' ' ' ALA . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.639 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.665 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.627 HD22 ' O ' ' T' ' 51' ' ' TRP . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.495 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' T' ' 36' ' ' LEU . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.545 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.545 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.2 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.758 HG12 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.758 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.745 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.627 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.705 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.742 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.785 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.858 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.858 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.705 ' NE1' HG21 ' T' ' 57' ' ' VAL . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.575 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.51 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.529 ' O ' HG23 ' T' ' 2' ' ' VAL . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.69 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.639 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' T' ' 97' ' ' ALA . 1.7 m-70 -131.43 -45.84 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' T' ' 27' ' ' GLY . . . 33.26 53.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.26 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 tttp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.938 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -61.45 -174.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -30.19 1.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -168.72 -16.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.3 161.42 25.28 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.425 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER -113.44 152.96 29.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.415 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.542 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.582 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.402 ' CE1' HG21 ' T' ' 75' ' ' ILE . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.582 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.624 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.624 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' T' ' 39' ' ' ALA . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.602 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 5.1 t60 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.673 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.851 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.611 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.447 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.735 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.913 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.913 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.711 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.846 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.529 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' T' ' 86' ' ' GLU . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.778 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.735 ' NE1' HG21 ' T' ' 57' ' ' VAL . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.611 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -110.5 7.7 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.916 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -83.85 50.18 1.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.678 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' T' ' 89' ' ' ASP . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -170.91 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.36 -42.48 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -169.3 23.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' T' ' 13' ' ' LYS . . . -122.81 166.9 15.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.412 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -112.94 148.8 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.763 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.422 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.772 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.422 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.658 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.664 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.55 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' T' ' 75' ' ' ILE . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.55 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.56 ' CZ ' ' HA2' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.559 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.559 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 45' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.672 HG12 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.558 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.672 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.861 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.7 ' O ' HD22 ' T' ' 30' ' ' LEU . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.568 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.575 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.568 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.717 HG21 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.938 HG21 ' HA2' ' T' ' 69' ' ' GLY . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.938 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.785 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.832 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.786 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.786 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.452 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.763 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' T' ' 57' ' ' VAL . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.654 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.598 ' O ' HG23 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.912 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.431 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 -102.21 13.27 35.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.912 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -85.83 44.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.944 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.469 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.596 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.773 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -60.26 -170.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -37.68 20.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -163.63 1.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.86 12.25 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.32 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 127.78 32.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.463 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.826 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.463 ' HB2' ' H ' ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.62 HD22 ' O ' ' T' ' 51' ' ' TRP . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.517 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.517 ' OE1' HG23 ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.538 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' T' ' 61' ' ' ILE . 6.3 t60 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.591 HG22 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.758 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.518 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.413 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.539 ' HA ' HD13 ' T' ' 80' ' ' ILE . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.645 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.758 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.572 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.822 HG22 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.822 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' T' ' 81' ' ' ARG . 1.8 m-20 -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.826 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.524 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.658 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.808 ' HA ' HD12 ' T' ' 14' ' ' LEU . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.756 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -115.3 5.06 14.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -81.58 51.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.423 ' O ' HD11 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -72.44 -169.94 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -55.84 -26.77 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -174.28 46.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.99 168.43 38.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -107.55 158.56 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.53 HG23 ' OE1' ' T' ' 18' ' ' GLU . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.53 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 26' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' T' ' 5' ' ' ARG . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.796 ' HA2' ' ND2' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.534 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.541 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.541 ' CD ' HG23 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' T' ' 36' ' ' LEU . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.519 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.519 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 4.8 t60 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.603 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.583 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.849 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.708 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.537 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.817 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.494 ' SG ' ' HE1' ' T' ' 45' ' ' HIS . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.869 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.894 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.671 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.535 ' HA2' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.594 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.594 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.614 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.429 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.817 ' NE1' HG21 ' T' ' 57' ' ' VAL . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.606 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.603 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.521 ' O ' HG23 ' T' ' 2' ' ' VAL . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.796 ' ND2' ' HA2' ' T' ' 28' ' ' GLY . 0.2 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -117.24 0.42 12.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -81.92 48.44 1.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.87 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.85 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -85.3 159.59 20.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -28.93 65.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -14.67 45.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 153.87 167.88 16.7 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.347 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.772 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? -83.39 153.2 24.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.733 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.71 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.644 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.577 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.531 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.509 ' CE1' HG21 ' T' ' 75' ' ' ILE . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' T' ' 75' ' ' ILE . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.578 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.497 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.801 HG12 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.801 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.741 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.682 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.617 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.795 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.837 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.837 HD11 ' HD2' ' T' ' 59' ' ' TYR . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.466 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.533 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.489 ' SG ' HG23 ' T' ' 61' ' ' ILE . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.81 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.554 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.588 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.554 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.795 ' NE1' HG21 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.527 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.639 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.761 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.85 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.677 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -130.31 15.83 5.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.562 ' HB2' ' CB ' ' T' ' 94' ' ' ASN . . . -82.85 52.0 2.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.878 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -106.27 151.64 24.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -66.48 -7.04 17.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.45 -27.87 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.97 172.52 19.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.283 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -58.14 131.01 49.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.869 HD11 ' O ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.664 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.459 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.664 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.86 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.537 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.562 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.607 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.607 ' CD ' HG23 ' T' ' 32' ' ' THR . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' T' ' 40' ' ' ARG . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.3 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.672 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.467 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.666 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.562 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.708 ' HA3' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.686 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.978 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.648 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.787 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.779 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.708 ' HD2' ' HA3' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.787 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.615 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.869 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' HG13 ' T' ' 46' ' ' VAL . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.654 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.952 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -112.29 11.77 20.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.952 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -84.86 47.63 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.407 ' HD3' HH11 ' T' ' 5' ' ' ARG . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.736 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -84.91 162.52 19.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.1 OUTLIER -62.6 -24.5 67.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.483 ' HB2' ' HZ1' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -93.0 -49.05 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -163.22 -173.52 32.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp -101.22 155.52 17.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.564 HG23 ' OE1' ' T' ' 18' ' ' GLU . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.564 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.584 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.7 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.666 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.486 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.486 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.645 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.528 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.528 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.481 ' HE1' HG23 ' T' ' 61' ' ' ILE . 16.7 t60 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.484 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.969 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.666 ' O ' HD22 ' T' ' 30' ' ' LEU . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.407 ' O ' ' HE1' ' T' ' 16' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.549 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.969 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.797 HD11 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' T' ' 36' ' ' LEU . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.901 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.901 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.811 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.538 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.801 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.597 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.623 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.7 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -117.62 -10.04 10.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.01 55.38 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.606 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.864 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.37 160.59 19.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 8' ' ' ARG . 16.7 mtm180 -65.15 -14.52 60.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 -29.46 11.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 162.38 173.27 30.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.421 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 23.6 ttpp -80.91 152.95 27.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.645 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.813 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.864 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.469 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.752 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.469 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.404 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.791 ' HA2' ' ND2' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.663 HD22 ' O ' ' T' ' 51' ' ' TRP . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.74 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.548 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.49 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.548 ' OE1' HG23 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.684 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.684 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.517 ' HE1' HG23 ' T' ' 61' ' ' ILE . 22.5 t60 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.482 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.645 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.663 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.779 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.86 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.671 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.86 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.632 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.861 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.861 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.813 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.779 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.671 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.791 ' ND2' ' HA2' ' T' ' 28' ' ' GLY . 0.2 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -116.23 -14.9 11.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.57 56.58 4.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.048 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.888 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.727 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.562 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.69 152.98 24.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -67.06 -15.93 64.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 93.7 p -96.13 -17.57 20.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 156.67 173.91 25.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? -58.92 146.81 36.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.474 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.474 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.773 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.703 HD22 ' O ' ' T' ' 51' ' ' TRP . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.58 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.58 ' OE1' HG23 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.538 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.554 ' HB2' HG23 ' T' ' 62' ' ' VAL . 1.5 t60 -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.615 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.665 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.786 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.703 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.899 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.899 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.887 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.576 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.513 ' NE ' ' H ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.535 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.769 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.713 ' HA ' HD12 ' T' ' 14' ' ' LEU . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.779 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.773 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -118.51 -6.66 10.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.02 55.44 2.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 98' ' ' LYS . . . . . 0.413 ' H ' ' HG3' ' T' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.893 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.62 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.657 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.626 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.14 155.74 18.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -16.39 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.6 p -97.49 -16.66 20.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 153.65 172.6 21.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.277 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm -58.4 148.13 28.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' T' ' 89' ' ' ASP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.57 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.709 HD22 ' O ' ' T' ' 51' ' ' TRP . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.632 HG23 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.632 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' T' ' 91' ' ' TYR . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.885 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.522 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.522 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.831 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.8 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.891 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.891 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.709 ' O ' HD22 ' T' ' 30' ' ' LEU . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.738 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.885 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.925 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.843 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 73' ' ' THR . . . . . 0.573 HG22 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.552 ' HA2' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.793 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.746 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.746 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.754 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.738 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.71 ' HA ' HD12 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.665 ' CB ' HD21 ' T' ' 36' ' ' LEU . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG23 ' T' ' 2' ' ' VAL . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.929 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -101.04 6.11 43.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.929 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -81.43 46.69 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.579 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -101.63 164.23 11.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -20.19 53.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.0 -47.31 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 172.5 -168.33 41.37 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.341 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt -66.18 139.61 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.701 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.856 HD11 ' O ' ' T' ' 89' ' ' ASP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.624 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.461 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' T' ' 30' ' ' LEU . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.646 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.523 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.646 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.558 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.548 ' HD2' ' HB1' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' HG23 ' T' ' 62' ' ' VAL . 4.4 t60 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.579 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.518 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.701 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.725 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.545 ' O ' HD12 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.54 ' HA ' HD13 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.682 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.856 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.856 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' T' ' 69' ' ' GLY . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.712 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.833 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.869 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.833 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.869 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.426 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.618 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.741 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.856 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.579 ' OH ' HG13 ' T' ' 46' ' ' VAL . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.17 6.79 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -85.67 55.83 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.703 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.732 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -79.81 145.69 32.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -52.11 -23.76 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -48.6 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -167.47 -178.01 39.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt -90.03 156.05 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.423 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.732 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.492 HG23 ' OE1' ' T' ' 18' ' ' GLU . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.795 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.671 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.621 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' T' ' 75' ' ' ILE . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.662 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.574 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 7.1 t60 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB1' HG13 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.671 ' O ' HD22 ' T' ' 30' ' ' LEU . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.591 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.485 ' C ' HD12 ' T' ' 80' ' ' ILE . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.828 HG13 ' HB1' ' T' ' 49' ' ' ALA . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.832 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.853 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.954 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.656 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.412 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.86 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.824 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.954 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.641 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.641 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.436 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.536 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.62 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.682 ' CD1' HG11 ' T' ' 57' ' ' VAL . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.795 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -121.1 8.74 10.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -84.6 48.06 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.638 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -60.71 -176.35 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -45.99 -40.59 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 87.1 p -157.45 -5.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.28 163.64 14.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.277 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -109.98 145.1 37.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.925 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.638 HD21 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.439 HG23 ' OE1' ' T' ' 18' ' ' GLU . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.817 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.648 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.746 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' T' ' 51' ' ' TRP . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.482 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' T' ' 75' ' ' ILE . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.482 ' CD ' HG23 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.573 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.527 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.527 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.412 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.761 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.625 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.568 ' HA3' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.675 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.77 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.623 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.549 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.82 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.82 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.817 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.446 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.925 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.675 ' NE1' HG21 ' T' ' 57' ' ' VAL . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.56 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.665 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.543 ' O ' HG23 ' T' ' 2' ' ' VAL . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.746 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -119.64 -6.9 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.02 55.04 2.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.569 HG23 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.597 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -67.16 -175.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -55.46 -33.47 63.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.61 49.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.51 164.33 29.82 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.414 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER -109.17 161.75 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.484 HG23 ' OE1' ' T' ' 18' ' ' GLU . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.484 ' OE1' HG23 ' T' ' 15' ' ' THR . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' T' ' 30' ' ' LEU . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.418 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.688 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.698 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.698 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.521 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.478 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.478 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.542 ' HE1' HG23 ' T' ' 61' ' ' ILE . 8.8 t60 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.642 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.642 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.896 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.688 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.412 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.716 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.74 ' HG3' HD12 ' T' ' 36' ' ' LEU . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.622 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' T' ' 36' ' ' LEU . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.866 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.866 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' T' ' 85' ' ' SER . 9.3 t-20 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.67 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.511 ' H ' ' C ' ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.716 ' NE1' HG21 ' T' ' 57' ' ' VAL . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.578 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.613 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.569 ' O ' HG23 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' T' ' 97' ' ' ALA . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -115.67 -8.87 12.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.519 ' HB2' ' ND2' ' T' ' 94' ' ' ASN . . . -82.38 55.94 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.625 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -78.08 -172.4 2.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.507 HH11 ' HB2' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -51.54 -36.87 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.8 7.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.02 164.96 12.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.43 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -106.21 142.12 36.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.412 HG23 ' OE1' ' T' ' 18' ' ' GLU . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' T' ' 22' ' ' VAL . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.649 ' HA2' HD21 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.611 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.611 ' CD ' HG23 ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.464 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.669 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.669 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.495 ' CG ' ' H ' ' T' ' 62' ' ' VAL . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.722 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.722 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.421 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.658 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.709 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.709 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.53 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.725 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.697 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.682 ' OH ' HG13 ' T' ' 46' ' ' VAL . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.851 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -122.77 16.7 10.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -79.25 47.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -66.02 -168.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -46.35 -38.87 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.418 ' H ' ' H ' ' T' ' 10' ' ' GLY . 0.6 OUTLIER -155.16 -14.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.2 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.418 ' H ' ' H ' ' T' ' 9' ' ' SER . . . -110.71 163.0 12.35 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.341 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER -113.83 152.74 30.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.923 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.941 HD21 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.647 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.5 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.587 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.516 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.525 ' HD1' ' HE1' ' T' ' 52' ' ' MET . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.516 ' CD ' HG23 ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.716 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.679 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.679 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 7.2 t60 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.57 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.57 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.587 ' O ' HD22 ' T' ' 30' ' ' LEU . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.525 ' HE1' ' HD1' ' T' ' 33' ' ' TYR . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.502 ' O ' HD12 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.494 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' T' ' 73' ' ' THR . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' T' ' 66' ' ' PRO . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' T' ' 65' ' ' GLY . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 73' ' ' THR . . . . . 0.404 HG22 ' HG3' ' T' ' 64' ' ' PRO . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' T' ' 36' ' ' LEU . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.865 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.865 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.487 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.723 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.941 ' HA ' HD21 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.698 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.68 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.637 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.0 -8.31 8.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.05 54.33 1.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -89.19 163.81 15.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.51 72.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.497 ' HB3' ' CD ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -85.15 -15.94 42.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.995 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 146.25 169.35 14.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.322 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.816 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt -75.7 146.91 39.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.521 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.781 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.918 HD11 ' O ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.667 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.688 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.456 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.697 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.526 HD22 ' O ' ' T' ' 51' ' ' TRP . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.54 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.54 ' CD ' HG23 ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.491 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.491 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.535 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.9 t60 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.401 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' HE2' ' T' ' 11' ' ' LYS . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.499 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.691 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HB3' ' HA3' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.763 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.591 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.411 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.706 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.706 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.781 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.918 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' T' ' 36' ' ' LEU . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.643 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.697 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -117.54 -11.14 10.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.9 53.97 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . -66.27 -169.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -26.33 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.7 t -172.38 47.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' T' ' 6' ' ' GLU . . . 174.63 166.6 32.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.387 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.51 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt -103.37 143.81 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.4 ' CZ ' ' HZ3' ' T' ' 88' ' ' TRP . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.834 ' CD1' ' HB2' ' T' ' 19' ' ' ALA . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.615 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' T' ' 15' ' ' THR . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.478 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.596 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.596 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.602 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.449 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.543 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.543 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.691 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.412 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.9 t60 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.527 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.537 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.858 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.655 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.693 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.858 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.937 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.713 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.753 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.937 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.769 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.769 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.412 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.856 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.777 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.831 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.582 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER -133.49 6.9 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -82.88 51.49 1.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.959 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.647 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -93.69 153.29 18.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -21.19 66.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -88.1 -16.6 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.51 168.4 15.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.349 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? -92.73 147.54 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.776 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.687 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.687 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' T' ' 7' ' ' ALA . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.604 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.516 HD13 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.589 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.444 ' CE1' HG21 ' T' ' 75' ' ' ILE . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.589 ' OE1' HG23 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.411 ' HA ' ' H ' ' T' ' 44' ' ' PHE . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.62 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.62 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.506 ' HE1' HG23 ' T' ' 61' ' ' ILE . 11.7 t60 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.803 HG22 ' H ' ' T' ' 48' ' ' ALA . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.651 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.803 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.646 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.47 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.849 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.849 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.429 ' C ' ' HD3' ' T' ' 64' ' ' PRO . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 70' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.936 HG22 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.936 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 11.5 t-20 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.632 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.776 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.785 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.872 ' HA ' HD21 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.684 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.689 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 1.063 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -126.03 24.4 6.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 1.063 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -81.78 48.31 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.962 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.636 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' T' ' 5' ' ' ARG . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.665 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.639 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.665 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.627 HD22 ' O ' ' T' ' 51' ' ' TRP . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.495 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' T' ' 36' ' ' LEU . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.545 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.545 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.749 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.758 HG12 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.758 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.745 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.627 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.705 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.52 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.742 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.785 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.858 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.858 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.705 ' NE1' HG21 ' T' ' 57' ' ' VAL . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.575 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.51 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.529 ' O ' HG23 ' T' ' 2' ' ' VAL . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.69 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.639 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.425 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.415 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.542 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.582 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.402 ' CE1' HG21 ' T' ' 75' ' ' ILE . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.582 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.624 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.624 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' T' ' 39' ' ' ALA . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.742 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.3 t-80 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.673 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.851 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.611 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.447 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.735 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.913 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.913 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.711 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.846 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.529 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' T' ' 86' ' ' GLU . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.778 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.735 ' NE1' HG21 ' T' ' 57' ' ' VAL . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.611 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.542 HD22 ' HA2' ' T' ' 28' ' ' GLY . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.678 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' T' ' 89' ' ' ASP . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.763 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.422 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.772 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.422 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.658 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.664 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.55 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' T' ' 75' ' ' ILE . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.55 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.56 ' CZ ' ' HA2' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.559 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.559 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.637 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.5 t-80 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.672 HG12 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.558 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.672 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.861 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.7 ' O ' HD22 ' T' ' 30' ' ' LEU . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.568 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.575 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.568 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.717 HG21 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.938 HG21 ' HA2' ' T' ' 69' ' ' GLY . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.568 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.938 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.785 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.832 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.786 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.786 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.452 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.763 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' T' ' 57' ' ' VAL . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.654 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.598 ' O ' HG23 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.664 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . 0.431 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.469 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.596 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.773 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.463 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.826 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.463 ' HB2' ' H ' ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.409 ' C ' HD22 ' T' ' 94' ' ' ASN . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.62 HD22 ' O ' ' T' ' 51' ' ' TRP . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.517 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.517 ' OE1' HG23 ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.538 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.525 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 15.0 t-160 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.591 HG22 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.758 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.518 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.413 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.539 ' HA ' HD13 ' T' ' 80' ' ' ILE . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.645 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.758 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.525 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.572 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.822 HG22 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.822 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.826 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.524 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.658 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.808 ' HA ' HD12 ' T' ' 14' ' ' LEU . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.756 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.63 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.423 ' O ' HD11 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.53 HG23 ' OE1' ' T' ' 18' ' ' GLU . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.53 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' T' ' 5' ' ' ARG . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.747 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.534 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.541 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.541 ' CD ' HG23 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' T' ' 36' ' ' LEU . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.519 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.519 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.715 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 3.0 t-80 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.603 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.583 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.849 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.708 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.537 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.817 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.532 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' T' ' 61' ' ' ILE . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.869 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.894 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.671 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.535 ' HA2' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.594 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.594 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.614 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.429 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.817 ' NE1' HG21 ' T' ' 57' ' ' VAL . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.606 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.603 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.521 ' O ' HG23 ' T' ' 2' ' ' VAL . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.747 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.85 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.772 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.733 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.71 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.644 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.577 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.531 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.509 ' CE1' HG21 ' T' ' 75' ' ' ILE . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' T' ' 75' ' ' ILE . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.578 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.497 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.801 HG12 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.801 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.741 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.682 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.617 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.795 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.837 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.837 HD11 ' HD2' ' T' ' 59' ' ' TYR . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.466 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.533 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . 0.489 ' SG ' HG23 ' T' ' 61' ' ' ILE . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.81 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.554 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.588 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.554 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.795 ' NE1' HG21 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.527 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.639 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.761 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.85 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.677 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.869 HD11 ' O ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.664 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.459 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.664 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.86 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.537 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.562 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.607 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.607 ' CD ' HG23 ' T' ' 32' ' ' THR . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' T' ' 40' ' ' ARG . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.672 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.467 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.666 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.562 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.708 ' HA3' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.686 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.978 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.648 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.787 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.779 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.708 ' HD2' ' HA3' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.787 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.615 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.869 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' HG13 ' T' ' 46' ' ' VAL . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.654 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.734 HD22 ' HA2' ' T' ' 28' ' ' GLY . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.407 ' HD3' HH11 ' T' ' 5' ' ' ARG . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.736 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.564 HG23 ' OE1' ' T' ' 18' ' ' GLU . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.564 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.584 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.7 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.666 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.486 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.486 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.645 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.528 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.528 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.688 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 8.6 t-80 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.484 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.969 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.666 ' O ' HD22 ' T' ' 30' ' ' LEU . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.407 ' O ' ' HE1' ' T' ' 16' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.549 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.969 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.797 HD11 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.593 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.484 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' T' ' 36' ' ' LEU . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.901 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.901 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.811 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.538 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.801 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.597 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.623 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.7 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.606 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.864 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 23.6 ttpp . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.645 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.813 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.864 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.469 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.752 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.469 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.404 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.754 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.663 HD22 ' O ' ' T' ' 51' ' ' TRP . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.74 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.548 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.49 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.548 ' OE1' HG23 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.684 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.684 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.665 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 9.5 t-80 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.482 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.645 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.663 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.779 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.86 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.671 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.86 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.632 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.861 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.861 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.578 HD21 ' HB3' ' T' ' 85' ' ' SER . 38.2 t30 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.578 ' HB3' HD21 ' T' ' 83' ' ' ASN . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.813 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.779 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.671 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.754 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.8 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.727 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.562 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.474 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.474 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.773 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.703 HD22 ' O ' ' T' ' 51' ' ' TRP . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.58 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.58 ' OE1' HG23 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.538 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.759 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.615 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.665 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.786 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.703 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.899 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.899 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.887 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.576 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.513 ' NE ' ' H ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.535 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.769 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.713 ' HA ' HD12 ' T' ' 14' ' ' LEU . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.779 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.773 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.62 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.657 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.626 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' T' ' 89' ' ' ASP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.57 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.573 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.709 HD22 ' O ' ' T' ' 51' ' ' TRP . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.632 HG23 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.632 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' T' ' 91' ' ' TYR . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.885 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.522 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.522 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.831 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.1 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.891 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.891 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.709 ' O ' HD22 ' T' ' 30' ' ' LEU . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.738 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.885 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.925 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.422 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.843 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . 0.573 HG22 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.552 ' HA2' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.793 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.746 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.746 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.754 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.738 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.71 ' HA ' HD12 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.665 ' CB ' HD21 ' T' ' 36' ' ' LEU . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG23 ' T' ' 2' ' ' VAL . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.488 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.579 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.701 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.856 HD11 ' O ' ' T' ' 89' ' ' ASP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.624 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.461 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' T' ' 30' ' ' LEU . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.646 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.523 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.646 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.558 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.548 ' HD2' ' HB1' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.766 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 2.3 t-80 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.579 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.518 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.701 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.725 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.545 ' O ' HD12 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.54 ' HA ' HD13 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.682 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.856 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.856 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' T' ' 69' ' ' GLY . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.712 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.833 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.869 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.833 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.869 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.426 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.618 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.741 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.856 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.579 ' OH ' HG13 ' T' ' 46' ' ' VAL . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' T' ' 95' ' ' PRO . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.703 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.732 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.423 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.732 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.492 HG23 ' OE1' ' T' ' 18' ' ' GLU . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.795 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.671 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.621 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' T' ' 75' ' ' ILE . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.662 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.574 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.688 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.5 t-80 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB1' HG13 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.671 ' O ' HD22 ' T' ' 30' ' ' LEU . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.591 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.485 ' C ' HD12 ' T' ' 80' ' ' ILE . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.828 HG13 ' HB1' ' T' ' 49' ' ' ALA . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.832 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.853 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.954 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.656 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.412 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.86 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.824 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.954 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.641 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.641 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.436 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.536 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.62 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.682 ' CD1' HG11 ' T' ' 57' ' ' VAL . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.795 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.638 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.925 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.638 HD21 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.439 HG23 ' OE1' ' T' ' 18' ' ' GLU . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.817 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.422 ' C ' HD22 ' T' ' 94' ' ' ASN . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.746 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' T' ' 51' ' ' TRP . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.482 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' T' ' 75' ' ' ILE . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.482 ' CD ' HG23 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.573 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.527 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.527 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.412 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.761 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.625 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.568 ' HA3' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.675 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.77 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.623 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.549 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.82 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.82 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.817 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.446 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.925 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.675 ' NE1' HG21 ' T' ' 57' ' ' VAL . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.56 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.665 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.543 ' O ' HG23 ' T' ' 2' ' ' VAL . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.746 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.569 HG23 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.597 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.484 HG23 ' OE1' ' T' ' 18' ' ' GLU . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.484 ' OE1' HG23 ' T' ' 15' ' ' THR . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' T' ' 30' ' ' LEU . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.688 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.698 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.698 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.521 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.478 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.478 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.605 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.6 t-160 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.642 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.642 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.896 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.688 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.412 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.716 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.74 ' HG3' HD12 ' T' ' 36' ' ' LEU . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.519 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.473 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.622 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' T' ' 36' ' ' LEU . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.866 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.866 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.75 HD21 ' HB3' ' T' ' 85' ' ' SER . 33.6 t30 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.67 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.75 ' HB3' HD21 ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.716 ' NE1' HG21 ' T' ' 57' ' ' VAL . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.578 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.613 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.569 ' O ' HG23 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.42 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.625 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.412 HG23 ' OE1' ' T' ' 18' ' ' GLU . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' T' ' 22' ' ' VAL . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.649 ' HA2' HD21 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.611 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.611 ' CD ' HG23 ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.464 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.669 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.669 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.589 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.722 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.722 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.421 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.658 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.709 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.709 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.53 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.725 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.697 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.682 ' OH ' HG13 ' T' ' 46' ' ' VAL . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.851 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.649 HD21 ' HA2' ' T' ' 28' ' ' GLY . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.923 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.941 HD21 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.647 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.5 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.587 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.516 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.525 ' HD1' ' HE1' ' T' ' 52' ' ' MET . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.516 ' CD ' HG23 ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.716 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.679 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.679 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.538 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 11.0 t-160 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.57 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.57 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.587 ' O ' HD22 ' T' ' 30' ' ' LEU . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.525 ' HE1' ' HD1' ' T' ' 33' ' ' TYR . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.502 ' O ' HD12 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.494 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.493 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.502 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' T' ' 73' ' ' THR . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' T' ' 66' ' ' PRO . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' T' ' 65' ' ' GLY . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . 0.404 HG22 ' HG3' ' T' ' 64' ' ' PRO . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' T' ' 36' ' ' LEU . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.865 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.865 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.487 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.723 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.941 ' HA ' HD21 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.698 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.68 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.637 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.816 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.521 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.781 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.918 HD11 ' O ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.667 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.688 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.456 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.697 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.526 HD22 ' O ' ' T' ' 51' ' ' TRP . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.54 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.54 ' CD ' HG23 ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.491 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.491 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.776 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 1.5 t-80 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.401 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' HE2' ' T' ' 11' ' ' LYS . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.499 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.691 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.54 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HB3' ' HA3' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.437 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.437 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 4.3 p30 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . 0.763 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.591 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.411 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.706 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.706 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.781 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.918 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' T' ' 36' ' ' LEU . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.643 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.697 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.51 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.4 ' CZ ' ' HZ3' ' T' ' 88' ' ' TRP . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.834 ' CD1' ' HB2' ' T' ' 19' ' ' ALA . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.615 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' T' ' 15' ' ' THR . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.478 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.596 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.596 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.602 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.449 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.543 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.543 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.691 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 17.0 t-160 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.527 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.537 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.858 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.655 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.693 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.858 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.937 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.445 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.713 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.753 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.937 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.769 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.769 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.556 HD21 ' HB2' ' T' ' 85' ' ' SER . 39.5 t30 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.556 ' HB2' HD21 ' T' ' 83' ' ' ASN . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.412 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.856 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.777 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.831 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.582 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' T' ' 96' ' ' HIS . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.647 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.776 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.687 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.687 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' T' ' 7' ' ' ALA . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.604 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.516 HD13 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.589 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.444 ' CE1' HG21 ' T' ' 75' ' ' ILE . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.589 ' OE1' HG23 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.411 ' HA ' ' H ' ' T' ' 44' ' ' PHE . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.62 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.62 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 10.8 t-160 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.803 HG22 ' H ' ' T' ' 48' ' ' ALA . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.651 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.803 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.646 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.47 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.849 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.849 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.573 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 66' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 67' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 68' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 70' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.936 HG22 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.936 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.678 HD21 ' HB3' ' T' ' 85' ' ' SER . 40.3 t30 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.632 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.678 ' HB3' HD21 ' T' ' 83' ' ' ASN . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.776 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.785 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.872 ' HA ' HD21 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.684 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.689 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.604 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 95' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.636 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -87.2 132.99 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -133.0 168.75 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 138.09 44.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' T' ' 5' ' ' ARG . 6.9 mmt-85 -145.33 156.44 43.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -103.73 -169.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -64.23 -170.87 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -47.39 -31.88 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.799 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.37 -19.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.7 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.32 159.85 23.54 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.1 ttmm -113.22 155.58 24.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.795 0.331 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 47.55 64.63 1.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.07 33.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 12.7 mt -108.68 151.31 26.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 43.3 p -105.75 -159.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.187 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 64.4 t80 -83.83 -56.04 3.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.41 -29.38 70.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -74.89 -58.46 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -49.54 -39.89 36.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.028 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 2.6 tttt -63.55 -50.5 69.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.61 91.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.29 34.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.575 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.665 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.3 m -65.58 -59.19 4.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.624 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 9.2 mt-10 -57.11 -21.77 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -85.02 -25.41 27.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.94 12.52 36.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.017 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' T' ' 97' ' ' ALA . . . 79.32 67.86 1.54 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.837 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.639 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 163.01 -170.11 38.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.675 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.665 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -149.42 170.74 17.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.289 . . . . 0.0 110.759 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.627 HD22 ' O ' ' T' ' 51' ' ' TRP . 38.2 mt -60.56 110.09 1.19 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.02 -165.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.211 0.529 . . . . 0.0 111.484 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.495 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -131.85 166.23 22.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.199 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 29.9 t80 -54.71 -53.03 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -52.99 -47.63 68.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -60.11 -35.55 75.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.374 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' T' ' 36' ' ' LEU . 0.1 OUTLIER -63.14 -33.01 74.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.24 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.77 -57.07 9.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.156 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.92 -29.99 13.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.204 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.545 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -78.71 -30.61 46.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.426 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -70.29 -35.73 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -59.88 -28.74 67.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.238 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.545 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -87.86 -16.6 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.99 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.68 45.06 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.11 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -96.72 82.6 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.749 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -107.99 119.74 40.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.053 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.758 HG12 ' H ' ' T' ' 48' ' ' ALA . 45.6 t -142.39 117.0 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.536 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -69.4 -3.36 13.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.033 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.758 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.33 87.19 6.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.745 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -38.94 129.23 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.264 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.15 125.58 7.93 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.742 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.627 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.2 m95 -62.65 121.34 13.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.914 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.2 178.16 7.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.964 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.51 -164.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 111.195 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -17.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.999 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 147.29 31.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.822 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' T' ' 52' ' ' MET . 13.1 ttm180 -84.97 133.4 34.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.742 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.705 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -114.68 142.59 26.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.333 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.42 163.4 37.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.128 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.8 p90 -145.0 104.09 4.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.368 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 33.9 Cg_endo -66.78 103.45 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.545 2.163 . . . . 0.0 111.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.7 mm -93.42 94.43 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.674 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.52 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 38.3 t -89.29 -34.5 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.62 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 4.5 tttm -107.47 100.69 35.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.579 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 18.6 Cg_endo -61.12 151.12 80.88 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.14 167.73 31.0 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.336 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 133.32 57.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.252 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.95 31.8 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.91 -77.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.742 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -60.11 107.45 1.34 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.031 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.95 6.96 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.652 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -94.92 163.46 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 10.9 p -114.88 124.95 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.09 173.94 13.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.894 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.6 mt -58.46 118.47 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.785 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -93.27 85.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.067 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -119.15 117.12 27.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.76 6.0 47.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.74 168.91 32.39 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.858 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.8 mm -46.03 134.85 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -96.39 26.72 4.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.858 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.18 17.83 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.0 t30 -165.89 108.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.2 OUTLIER -81.6 25.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.009 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.6 11.47 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 2.9 mm-40 -63.81 175.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.978 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 4.5 mtp-105 -115.56 97.65 6.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.623 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.705 ' NE1' HG21 ' T' ' 57' ' ' VAL . 45.1 m95 -137.3 -158.98 0.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.575 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.5 OUTLIER -107.92 -141.65 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.247 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -161.01 121.39 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.571 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.51 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 4.9 m-85 -91.22 74.91 6.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.529 ' O ' HG23 ' T' ' 2' ' ' VAL . 88.8 m -56.51 172.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.404 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.69 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.4 t80 -160.9 132.76 5.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.639 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 1.0 OUTLIER -170.17 119.94 0.55 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.978 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 20.8 Cg_endo -61.52 -6.02 6.44 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.442 2.095 . . . . 0.0 111.771 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' T' ' 97' ' ' ALA . 1.7 m-70 -131.43 -45.84 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' T' ' 27' ' ' GLY . . . 33.26 53.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.26 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 tttp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.938 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -86.98 129.09 39.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 111.187 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -128.01 161.52 28.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.97 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.42 135.64 40.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.852 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -145.75 149.41 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.934 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -102.5 -168.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -61.45 -174.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -30.19 1.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -168.72 -16.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.3 161.42 25.28 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.425 ' HD3' ' CB ' ' T' ' 6' ' ' GLU . 0.4 OUTLIER -113.44 152.96 29.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.755 0.312 . . . . 0.0 111.076 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 47.41 61.45 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -167.89 23.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.711 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.5 mt -97.76 146.24 25.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.415 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.8 p -104.78 -161.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 61.0 t80 -84.33 -58.06 2.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.643 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.14 70.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.8 mt-10 -75.29 -51.18 13.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.328 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.96 -42.49 72.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.028 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' T' ' 30' ' ' LEU . 6.1 tttt -63.11 -46.58 86.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -44.51 95.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.031 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -55.23 -37.7 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.717 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.9 OUTLIER -67.25 -56.9 7.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.774 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.3 mt-10 -62.23 -17.03 57.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.146 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -87.64 -32.83 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -90.69 -2.17 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.93 67.11 1.0 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.918 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.542 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . 168.07 -167.73 40.33 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -147.13 168.71 20.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' T' ' 20' ' ' LYS . 26.4 mt -62.33 115.44 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.16 -166.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.459 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.582 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.31 164.31 27.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.323 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.402 ' CE1' HG21 ' T' ' 75' ' ' ILE . 37.0 t80 -53.43 -55.39 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -52.77 -47.7 67.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.557 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.582 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.0 mt-30 -58.45 -34.04 70.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.14 -36.21 82.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.137 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -62.05 -56.84 14.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.87 20.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.081 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -73.08 -30.15 63.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.366 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -35.69 59.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.647 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -54.14 -20.46 6.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.381 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.624 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -98.57 -31.79 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.624 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.36 41.72 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.924 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.418 ' CD2' ' HB1' ' T' ' 39' ' ' ALA . 3.9 t80 -87.95 77.97 8.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.742 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.3 t-80 -90.6 117.5 29.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.276 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.673 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.7 t -148.16 120.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.076 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.611 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.3 OUTLIER -84.4 -2.23 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.673 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -91.22 88.15 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.654 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.851 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.02 126.17 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.58 126.98 8.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.711 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.611 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 87.7 m95 -58.61 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 111.089 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.447 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 1.9 ptp -146.05 -170.1 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -52.87 151.94 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.22 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.83 -8.95 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 85.58 34.49 13.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.936 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 13.0 ttm180 -88.23 151.46 22.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.758 0.314 . . . . 0.0 110.711 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.735 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.2 m -132.7 146.82 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.281 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.62 163.28 32.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.976 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.913 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.5 p90 -140.69 98.95 6.97 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.787 0.327 . . . . 0.0 111.527 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.4 Cg_endo -64.21 101.75 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.578 2.185 . . . . 0.0 111.802 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.913 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.0 mm -93.71 107.62 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.673 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 11.6 t -97.14 -21.99 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.57 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 6.5 ttmt -124.27 91.84 48.99 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.705 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.01 130.41 27.6 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.541 2.16 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.711 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . -156.99 165.24 33.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.365 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.13 148.32 50.09 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.626 2.218 . . . . 0.0 112.404 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 56.12 31.56 18.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 -75.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.846 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -57.71 127.72 45.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.976 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.69 -4.91 57.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.97 -72.63 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.677 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -178.07 2.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.811 0.339 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 73.7 p -118.29 130.17 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.65 170.29 13.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.964 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -64.6 119.25 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.529 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -92.43 86.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.33 109.97 12.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 13.79 2.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.93 165.11 17.73 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.6 mm -51.55 141.5 4.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' T' ' 83' ' ' ASN . 5.9 mmm180 -104.27 16.19 26.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.9 mm? 69.46 -18.4 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.995 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.2 OUTLIER -116.77 106.27 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.598 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -85.72 28.09 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -112.58 21.9 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.982 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' T' ' 86' ' ' GLU . 3.6 mt-10 -71.42 174.08 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.778 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 26.6 mtm-85 -111.11 89.06 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.619 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.735 ' NE1' HG21 ' T' ' 57' ' ' VAL . 29.6 m95 -126.54 -145.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.058 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.611 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -122.54 -138.49 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -166.34 113.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.91 0.386 . . . . 0.0 111.453 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.594 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.0 m-85 -83.16 73.62 10.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.665 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 1.0 OUTLIER -49.72 163.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.406 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -159.26 122.34 3.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.126 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 23.6 t-20 -155.9 119.92 2.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.681 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 -15.92 44.09 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.761 2.308 . . . . 0.0 112.131 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -110.5 7.7 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.689 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.916 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -83.85 50.18 1.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.678 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -71.26 134.59 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -131.94 165.93 22.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.42 139.46 40.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.156 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.4 mmt-85 -144.64 178.31 8.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.65 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' T' ' 89' ' ' ASP . 0.7 OUTLIER -129.19 -167.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.955 0.407 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -170.91 0.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.36 -42.48 10.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -169.3 23.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' T' ' 13' ' ' LYS . . . -122.81 166.9 15.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.412 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -112.94 148.8 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.975 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 22.4 m-85 38.88 59.43 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.763 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -153.38 18.97 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.1 mt -95.86 144.61 26.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.422 HG23 ' OE1' ' T' ' 18' ' ' GLU . 39.9 p -102.34 -161.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.772 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 69.6 t80 -84.6 -58.7 2.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.74 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.818 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.422 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.4 mt-10 -75.38 -49.34 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.25 68.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.826 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.658 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 13.4 tttp -65.2 -51.8 58.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.81 87.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.724 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.95 -37.64 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.214 0.531 . . . . 0.0 110.251 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -69.9 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.254 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -51.72 -21.43 2.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.291 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -89.52 -28.2 19.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.075 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -93.65 19.81 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.17 65.52 2.25 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.976 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.664 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 167.68 -168.42 40.62 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -149.36 172.28 15.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.697 0.284 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.7 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.9 mt -64.23 105.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -56.05 -167.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.69 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.55 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -132.02 166.53 21.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' T' ' 75' ' ' ILE . 40.5 t80 -54.32 -55.62 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.739 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -51.86 -47.28 64.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.466 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.55 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.0 mt-30 -58.29 -34.69 70.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.228 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.7 OUTLIER -64.43 -32.86 74.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.002 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.3 -57.5 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.245 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.1 -30.89 28.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.18 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.24 -30.05 64.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.212 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.56 ' CZ ' ' HA2' ' T' ' 74' ' ' GLY . 3.6 ttt180 -71.59 -35.56 70.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.338 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.7 mttt -52.16 -35.46 48.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.559 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.94 -30.09 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.559 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 123.94 47.07 0.25 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.475 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -86.32 87.53 7.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.768 0.318 . . . . 0.0 110.477 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.637 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.5 t-80 -103.08 109.72 21.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.327 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.672 HG12 ' H ' ' T' ' 48' ' ' ALA . 42.9 t -142.72 110.52 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.728 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.558 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.39 0.24 8.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.672 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -96.65 91.27 5.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.861 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -40.41 139.4 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' OD1' ' T' ' 89' ' ' ASP . . . -114.17 148.95 18.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.897 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.7 ' O ' HD22 ' T' ' 30' ' ' LEU . 95.6 m95 -83.11 136.17 34.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.568 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.0 ptt? -144.75 -168.24 2.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.785 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.0 148.3 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.575 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 60.61 18.41 8.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.61 20.33 59.15 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.801 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.568 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 25.9 ttm180 -67.75 138.14 55.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.717 HG21 ' CD1' ' T' ' 88' ' ' TRP . 1.2 m -130.98 139.26 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.728 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -166.28 161.58 35.23 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.048 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -129.61 104.22 17.49 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 0.0 111.235 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 15.0 Cg_exo -66.58 91.58 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.95 2.433 . . . . 0.0 111.91 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.938 HG21 ' HA2' ' T' ' 69' ' ' GLY . 5.7 mm -84.12 141.76 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.385 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.568 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 71.7 t -141.8 -27.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.7 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 5.2 tptm -116.92 89.35 29.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.784 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 60.6 Cg_exo -49.62 159.42 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 0.0 112.369 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.09 176.07 40.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.315 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.75 6.22 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.774 2.316 . . . . 0.0 112.399 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' C ' ' T' ' 65' ' ' GLY . 10.1 p30 178.51 60.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.23 -69.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.938 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.1 136.81 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.982 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -88.84 9.43 24.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 110.795 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.37 -45.06 1.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.684 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 173.31 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.328 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 2.9 p -118.77 126.24 51.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 150.32 167.17 14.15 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.975 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.785 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -63.25 125.07 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.832 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.15 86.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.046 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -121.49 121.06 36.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -89.82 5.51 45.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.09 168.38 41.42 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.786 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.3 mm -51.8 139.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 17.0 25.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.786 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.1 mm? 56.16 15.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -155.69 98.29 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -79.26 34.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.77 7.21 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.452 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.0 OUTLIER -67.19 171.18 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.763 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 46.3 mtt-85 -113.09 92.09 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.539 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' T' ' 57' ' ' VAL . 51.7 m95 -130.22 -174.89 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.012 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.679 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -89.6 -169.84 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.356 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.679 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -134.28 117.84 16.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.654 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 4.0 m-85 -90.22 76.26 6.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.598 ' O ' HG23 ' T' ' 2' ' ' VAL . 73.6 m -57.13 172.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.7 t80 -162.27 130.07 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.241 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.912 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 18.6 t-20 -166.34 119.98 0.86 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 18.9 Cg_endo -58.93 -25.59 77.82 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.819 2.346 . . . . 0.0 112.335 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.431 ' N ' ' OD1' ' T' ' 94' ' ' ASN . 2.0 m-70 -102.21 13.27 35.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.912 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -85.83 44.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.944 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -81.84 124.3 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 111.122 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -120.16 162.37 19.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.469 ' HB3' ' HZ ' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -101.48 139.15 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.968 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' T' ' 5' ' ' ARG . 13.5 mmt180 -144.01 146.68 33.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.775 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.596 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -99.43 -168.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.773 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -60.26 -170.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -37.68 20.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -163.63 1.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.86 12.25 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.32 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 127.78 32.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 41.3 m-85 61.73 -141.37 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER 63.06 19.35 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.117 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' T' ' 89' ' ' ASP . 16.4 mt -103.46 153.42 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.938 0.399 . . . . 0.0 111.233 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.463 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 55.5 p -111.36 -158.87 0.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.826 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.3 t80 -83.0 -54.37 5.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.607 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.28 68.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.888 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.463 ' HB2' ' H ' ' T' ' 15' ' ' THR . 81.3 mt-10 -73.24 -54.71 7.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -52.24 -45.71 65.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.951 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 16.1 tttm -60.78 -42.76 98.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.03 77.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.72 -35.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.761 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.0 OUTLIER -65.9 -57.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -59.5 -15.88 20.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.08 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -92.41 -31.06 15.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.036 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.65 -4.6 55.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 97.5 66.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.02 -168.93 39.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.641 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 14.9 p-80 -148.77 172.1 15.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.956 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.62 HD22 ' O ' ' T' ' 51' ' ' TRP . 34.1 mt -62.12 109.74 1.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.705 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.96 -165.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.517 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -129.03 170.57 13.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.159 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -58.92 -54.24 49.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.22 -46.67 69.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.517 ' OE1' HG23 ' T' ' 32' ' ' THR . 82.3 mt-30 -60.64 -35.53 76.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.5 OUTLIER -66.65 -28.51 68.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.747 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 19.4 tp10 -63.74 -58.77 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.199 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -32.22 54.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.005 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.6 -33.46 75.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.516 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -80.46 -35.08 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.661 178.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -50.09 -29.01 8.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.772 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pp -93.86 -33.31 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.538 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.46 48.06 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.501 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.698 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -82.36 91.76 6.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.658 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.525 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 15.0 t-160 -97.84 123.59 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.591 HG22 ' H ' ' T' ' 48' ' ' ALA . 0.9 OUTLIER -173.11 116.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -78.6 6.01 9.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.291 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.591 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -93.32 89.02 6.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.758 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.48 121.84 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.137 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.15 121.58 7.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.761 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 92.1 m95 -55.34 152.22 8.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.776 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.518 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.9 ptp -152.79 -170.51 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.47 150.7 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.413 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.5 OUTLIER 65.48 -1.94 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.005 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 82.55 17.13 69.22 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.539 ' HA ' HD13 ' T' ' 80' ' ' ILE . 13.5 ttm180 -68.17 144.18 55.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.645 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -133.85 138.98 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.81 165.19 38.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.219 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.758 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.1 p90 -139.07 94.07 10.04 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.753 0.311 . . . . 0.0 111.368 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.3 Cg_endo -60.81 93.67 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.555 2.17 . . . . 0.0 111.917 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.693 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.4 mm -87.78 118.46 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.4 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.525 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 60.8 t -97.38 -33.33 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 17.8 tttp -116.71 90.55 31.94 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.63 164.58 4.2 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.619 2.213 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.56 -174.85 42.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.352 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.34 130.89 22.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.646 2.23 . . . . 0.0 112.194 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 60.39 17.52 7.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -166.18 70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.59 110.36 1.36 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -76.23 0.16 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.363 . . . . 0.0 110.997 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.53 -16.1 14.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.669 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 -178.65 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -142.05 119.38 11.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.63 -177.66 22.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.962 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.0 mt -65.28 117.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 111.055 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.572 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.6 OUTLIER -92.75 86.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.944 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 117.27 20.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.967 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.09 13.44 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.87 170.0 16.14 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.822 HG22 ' H ' ' T' ' 82' ' ' LEU . 27.1 mm -53.41 139.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' T' ' 83' ' ' ASN . 1.9 mmm180 -111.38 11.13 21.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.79 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.822 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.4 OUTLIER 64.27 -7.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -120.42 83.11 2.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.826 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -71.84 25.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.926 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.524 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -99.02 4.89 47.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.3 OUTLIER -61.9 172.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.855 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.2 OUTLIER -116.26 95.94 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.658 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 37.4 m95 -130.46 -149.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 111.085 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.808 ' HA ' HD12 ' T' ' 14' ' ' LEU . 2.6 m-20 -116.07 -138.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.37 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -164.26 120.7 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 111.364 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.3 m-85 -87.53 73.85 9.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 m -51.65 158.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.756 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -153.25 124.46 7.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.436 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 45.5 t-20 -169.43 115.88 0.53 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.839 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 26.7 Cg_endo -63.14 -7.15 11.15 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.614 2.209 . . . . 0.0 112.232 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -115.3 5.06 14.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.774 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -81.58 51.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.25 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.1 p -76.61 132.26 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 111.222 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.13 164.74 23.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 145.24 25.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -143.64 153.35 42.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.937 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.423 ' O ' HD11 ' T' ' 14' ' ' LEU . 2.2 mp0 -102.93 -171.71 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -72.44 -169.94 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -55.84 -26.77 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -174.28 46.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.99 168.43 38.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -107.55 158.56 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.13 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' T' ' 87' ' ' ARG . 6.2 m-30 49.05 66.57 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.06 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -173.47 28.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 11.5 mt -110.33 139.46 45.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.53 HG23 ' OE1' ' T' ' 18' ' ' GLU . 29.7 p -97.42 -161.04 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.5 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 48.7 t80 -81.69 -64.97 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 110.715 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.18 -31.04 66.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.53 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.4 mt-10 -72.56 -46.68 53.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.321 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.85 80.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.003 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.68 -46.28 88.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.003 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.08 68.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.63 -37.78 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.361 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.23 -61.02 1.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.426 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.3 OUTLIER -57.12 -10.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.14 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.4 -28.55 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' T' ' 5' ' ' ARG . 0.9 OUTLIER -97.52 -4.19 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.969 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 100.77 66.19 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.723 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.747 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 175.05 -165.58 36.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.623 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -152.46 175.4 12.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.722 0.296 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.534 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.8 mt -66.45 109.74 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.92 -166.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.15 0.5 . . . . 0.0 111.455 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.541 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -132.96 165.42 24.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.238 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.9 t80 -55.0 -52.33 63.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.641 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -47.95 70.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.542 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.541 ' CD ' HG23 ' T' ' 32' ' ' THR . 94.5 mt-30 -59.77 -35.76 75.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' T' ' 36' ' ' LEU . 0.2 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.997 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -62.81 -57.74 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.217 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.0 -30.91 27.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.162 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.25 -30.35 66.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.117 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -71.33 -35.05 71.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.455 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 2.9 mttm -52.07 -35.1 46.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.198 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.519 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.45 -28.2 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.519 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 121.21 46.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.317 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.2 t80 -85.66 86.51 7.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.537 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.715 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 3.0 t-80 -104.3 111.69 24.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.603 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 3.4 t -143.49 121.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.69 0.24 24.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.173 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.583 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -95.6 95.14 8.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 0.0 110.784 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.849 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -48.46 118.96 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.268 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -98.75 128.56 9.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.708 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 94.2 m95 -61.72 148.49 42.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 0.8 OUTLIER -143.53 -168.81 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -53.81 149.14 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.224 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.35 -19.14 0.26 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 98.99 28.65 7.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.714 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.537 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 0.6 OUTLIER -81.27 148.45 29.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.584 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.817 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.3 m -134.04 138.82 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.911 0.386 . . . . 0.0 111.307 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.57 161.25 34.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.229 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.1 p90 -140.36 105.88 6.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 111.254 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 42.5 Cg_endo -70.02 102.38 1.06 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.574 2.183 . . . . 0.0 111.979 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.3 mm -94.24 99.65 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.535 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.532 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 41.0 t -95.21 -26.3 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.799 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -120.81 95.27 48.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 19.5 Cg_endo -60.08 161.43 19.29 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.575 2.183 . . . . 0.0 112.113 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -165.61 176.63 41.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.237 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 12.28 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.737 2.291 . . . . 0.0 112.496 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' T' ' 65' ' ' GLY . 6.9 p30 178.79 61.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' T' ' 61' ' ' ILE . 23.5 t -174.87 -59.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.869 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -69.0 117.79 8.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.996 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.91 1.6 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -70.85 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.684 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -87.13 176.83 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p -115.77 125.32 52.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.47 169.07 16.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.934 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.6 mt -57.14 116.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.888 0.375 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.894 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.35 86.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.842 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.671 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.1 OUTLIER -128.67 131.43 48.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.029 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.76 22.03 15.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.559 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.535 ' HA2' ' HG3' ' T' ' 56' ' ' ARG . . . 58.68 -179.07 1.48 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.594 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.8 mm -50.49 110.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' T' ' 81' ' ' ARG . 0.0 OUTLIER -86.4 15.68 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.937 0.399 . . . . 0.0 110.85 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.594 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.4 mm? 68.56 46.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.017 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.614 ' HB3' ' HD2' ' T' ' 81' ' ' ARG . 2.2 t-20 -176.51 86.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.81 20.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.813 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.429 ' H ' ' C ' ' T' ' 83' ' ' ASN . 43.9 m -122.78 25.96 8.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.999 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.3 mm-40 -70.83 -173.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 87' ' ' ARG . 3.8 mtm180 -111.94 74.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.817 ' NE1' HG21 ' T' ' 57' ' ' VAL . 32.5 m95 -114.88 -157.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.213 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.606 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 2.2 m-20 -113.68 -144.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.233 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -159.29 119.64 3.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 111.435 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.603 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 5.4 m-85 -91.87 75.62 5.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.676 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.521 ' O ' HG23 ' T' ' 2' ' ' VAL . 64.0 m -54.27 166.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.288 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -159.91 136.57 9.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.301 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.747 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -171.4 133.65 0.88 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.649 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -83.01 -6.52 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.554 2.169 . . . . 0.0 110.932 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -117.24 0.42 12.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.693 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -81.92 48.44 1.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.87 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.85 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.4 p -86.68 130.7 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.49 169.28 12.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -111.23 137.72 48.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.907 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -144.69 156.97 44.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.04 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.6 pm0 -109.87 -167.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -85.3 159.59 20.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -28.93 65.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -14.67 45.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 153.87 167.88 16.7 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.347 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.772 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 4.0 ttpm? -83.39 153.2 24.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 61.72 69.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.733 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -177.45 21.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.959 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 26.3 mt -97.82 147.82 24.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 69.3 p -102.4 -159.86 0.75 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.71 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 62.2 t80 -83.04 -52.33 6.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.964 0.412 . . . . 0.0 110.513 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.55 -29.95 66.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.857 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' T' ' 15' ' ' THR . 79.6 mt-10 -72.4 -52.94 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.226 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.81 64.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.844 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -60.73 -42.11 96.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.58 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.58 -36.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -66.3 -56.36 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.701 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.48 -19.17 14.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.111 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -88.39 -29.59 20.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -100.18 24.37 8.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.05 66.69 2.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.871 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.677 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 172.48 -178.64 44.49 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.677 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.644 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 2.9 p-80 -148.29 170.98 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.577 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.0 mt -60.27 109.01 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -62.82 -166.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.553 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.531 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.96 167.62 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.254 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.509 ' CE1' HG21 ' T' ' 75' ' ' ILE . 12.9 t80 -55.58 -50.75 69.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -47.05 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' T' ' 32' ' ' THR . 29.6 mt-30 -59.03 -36.52 75.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.312 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' T' ' 75' ' ' ILE . 1.3 mm? -63.3 -31.19 72.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.152 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -65.44 -58.22 6.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.305 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.54 -28.93 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.266 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' T' ' 44' ' ' PHE . . . -81.62 -29.54 33.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.5 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -36.95 81.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.684 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 5.5 pttt -59.39 -30.56 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.578 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.7 OUTLIER -83.72 -27.37 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.672 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.47 46.03 0.37 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.497 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.8 OUTLIER -87.38 79.64 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.341 . . . . 0.0 110.668 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.71 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 7.9 t-80 -102.62 113.15 26.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.355 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.801 HG12 ' H ' ' T' ' 48' ' ' ALA . 58.0 t -148.78 118.34 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.456 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -74.2 -0.11 15.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.801 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -93.44 91.46 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.791 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.741 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -43.31 133.7 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.227 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -109.32 124.58 7.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.838 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.682 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 75.2 m95 -60.8 126.02 25.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 0.0 110.985 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -130.19 -169.6 2.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.964 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.78 152.37 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.479 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.617 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.3 mttp 58.95 22.17 10.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.082 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 61.59 17.81 54.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.796 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' T' ' 52' ' ' MET . 24.0 ttm180 -66.74 143.96 56.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 0.0 110.674 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.795 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -135.96 137.7 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.148 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -164.86 162.17 35.36 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.211 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.837 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.4 OUTLIER -135.95 101.76 10.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.845 0.355 . . . . 0.0 111.129 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 22.3 Cg_exo -62.59 99.48 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 0.0 112.039 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.837 HD11 ' HD2' ' T' ' 59' ' ' TYR . 6.3 mm -93.97 98.52 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.284 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.466 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 5.0 t -95.65 -24.66 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.309 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.8 tptt -115.67 76.19 5.56 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.74 141.91 61.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.605 2.204 . . . . 0.0 112.418 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.92 -98.63 0.11 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.263 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.533 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 63.2 Cg_endo -73.51 -129.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.694 2.263 . . . . 0.0 112.18 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 10.9 p30 -62.78 1.07 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.172 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.489 ' SG ' HG23 ' T' ' 61' ' ' ILE . 5.5 t -108.92 116.54 32.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.94 117.69 3.33 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.977 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -2.52 58.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.65 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.633 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.76 166.4 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 0.0 110.924 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 41.4 p -112.49 119.64 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 177.46 17.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.972 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.05 125.88 15.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.81 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -97.28 88.66 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.081 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -120.96 124.76 45.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.991 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -99.68 18.5 17.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.82 172.44 21.75 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.849 HG22 ' H ' ' T' ' 82' ' ' LEU . 10.6 mm -56.89 144.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 111.171 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.554 ' HG3' ' CD ' ' T' ' 86' ' ' GLU . 1.3 mmm180 -100.91 0.34 38.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.849 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 76.83 -29.88 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.799 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.0 OUTLIER -109.77 95.41 5.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.709 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 30.3 ptt180 -65.83 19.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.206 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.588 ' H ' ' C ' ' T' ' 83' ' ' ASN . 72.6 m -95.24 8.26 43.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.221 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.554 ' CD ' ' HG3' ' T' ' 81' ' ' ARG . 1.5 mt-10 -64.2 150.56 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -95.83 85.6 4.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.905 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.795 ' NE1' HG21 ' T' ' 57' ' ' VAL . 34.1 m95 -121.87 -169.57 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.953 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.527 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.9 OUTLIER -99.72 -141.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -163.65 126.46 2.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.334 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.639 ' OH ' ' HB ' ' T' ' 46' ' ' VAL . 10.1 m-85 -95.01 76.14 3.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.761 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.0 m -53.41 153.9 3.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.936 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.85 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -155.94 123.28 5.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.677 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 1.1 t30 -150.23 127.82 5.64 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.77 -4.64 10.26 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.456 2.104 . . . . 0.0 111.96 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -130.31 15.83 5.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.562 ' HB2' ' CB ' ' T' ' 94' ' ' ASN . . . -82.85 52.0 2.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.878 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.53 129.56 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.431 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.9 160.09 32.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.835 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 144.03 26.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 64.8 mmt-85 -142.9 157.05 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.11 -165.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.647 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -106.27 151.64 24.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.065 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -66.48 -7.04 17.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.45 -27.87 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.97 172.52 19.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.283 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -58.14 131.01 49.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 17.2 m-30 56.72 69.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.615 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 50.1 mttm -152.05 -3.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.601 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.869 HD11 ' O ' ' T' ' 89' ' ' ASP . 3.5 pp -99.71 167.45 10.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.664 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 11.4 p -118.02 -156.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.374 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.459 ' CB ' ' HB3' ' T' ' 84' ' ' ARG . 92.5 t80 -79.81 -56.12 4.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.92 -31.62 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.664 ' HB2' ' H ' ' T' ' 15' ' ' THR . 30.6 mt-10 -73.89 -58.81 3.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.961 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.86 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -47.47 -39.49 15.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.537 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 10.8 tttp -64.8 -50.99 64.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.268 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.16 94.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.13 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.73 -39.21 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.093 0.473 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.73 -59.05 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.812 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.0 OUTLIER -58.27 -10.77 2.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.419 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.27 -32.25 24.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.547 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.78 -4.63 52.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 67.15 0.85 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.815 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' T' ' 94' ' ' ASN . . . -179.97 -164.88 32.95 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.545 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.0 164.18 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.562 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.9 mt -63.12 120.29 11.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.705 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.7 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.467 . . . . 0.0 111.284 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.607 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -137.22 161.09 37.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.262 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.8 t80 -51.05 -54.15 27.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -48.21 67.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.493 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.607 ' CD ' HG23 ' T' ' 32' ' ' THR . 86.6 mt-30 -59.58 -33.58 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.423 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -65.18 -32.89 74.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.126 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -64.38 -57.69 8.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.75 30.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.15 -30.11 62.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.372 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' T' ' 40' ' ' ARG . 5.0 ttp85 -75.6 -36.25 60.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.687 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -51.6 -25.3 6.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.164 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.667 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -93.94 -33.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.667 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.03 42.15 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -91.35 79.55 5.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.857 0.361 . . . . 0.0 110.686 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.687 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -103.28 134.86 45.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.184 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.672 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -159.08 131.94 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.467 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -86.63 59.23 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.331 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.666 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -154.24 90.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.803 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -40.69 133.04 2.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.489 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -113.88 119.1 4.65 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.817 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.562 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.3 m95 -56.08 121.17 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' T' ' 32' ' ' THR . 1.2 ptt? -139.76 175.06 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.36 -165.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.178 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.27 -37.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.716 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.708 ' HA3' ' HD2' ' T' ' 84' ' ' ARG . . . 167.67 35.54 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.84 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -84.58 149.57 25.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 110.743 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.686 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -129.75 146.6 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.467 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -174.69 157.88 25.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.16 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.978 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.9 p90 -142.4 101.31 5.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.901 0.381 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.3 Cg_endo -62.99 114.91 2.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.539 2.159 . . . . 0.0 111.622 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' T' ' 59' ' ' TYR . 10.3 mm -107.16 93.69 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.424 . . . . 0.0 111.776 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 41.1 t -85.77 -33.93 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.678 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -118.19 91.45 40.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.84 166.29 10.5 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' T' ' 68' ' ' CYS . . . 154.01 169.52 18.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.231 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.83 169.68 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.534 2.156 . . . . 0.0 112.17 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 t30 47.44 34.93 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 65' ' ' GLY . 11.2 m -155.75 -47.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.758 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.58 122.23 5.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.925 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.9 92.94 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.76 70.62 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.612 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 tptt 44.59 -167.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.96 0.409 . . . . 0.0 111.326 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' T' ' 61' ' ' ILE . 16.3 p -116.89 117.62 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.136 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.73 170.76 14.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.001 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -59.57 119.89 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.648 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -90.8 85.95 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -116.64 108.11 15.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.033 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -84.78 4.07 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.86 161.96 31.34 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -48.81 147.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.179 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.787 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.8 mmp_? -100.58 20.61 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.779 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 61.74 12.97 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.29 126.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.708 ' HD2' ' HA3' ' T' ' 55' ' ' GLY . 1.4 mmt85 -81.71 31.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.986 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -95.45 0.63 53.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.787 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 1.1 mm-40 -70.3 163.0 27.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.936 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.615 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.1 OUTLIER -112.05 116.94 31.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.5 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 44.3 m95 -145.92 -149.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.615 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.869 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -115.55 -147.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.647 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.514 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -161.6 124.56 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.892 0.377 . . . . 0.0 111.611 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' OH ' HG13 ' T' ' 46' ' ' VAL . 8.1 m-85 -89.71 74.14 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.654 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -43.53 157.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.511 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -159.61 120.34 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.304 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.952 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 23.7 t-20 -154.37 118.2 2.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 17.9 Cg_endo -60.05 -15.59 34.47 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.216 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -112.29 11.77 20.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.661 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.952 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -84.86 47.63 1.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.2 p -79.11 131.15 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.303 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -134.89 165.21 25.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.927 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 137.59 38.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.407 ' HD3' HH11 ' T' ' 5' ' ' ARG . 0.1 OUTLIER -141.08 146.89 37.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 3.8 pm0 -95.06 -168.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.393 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.736 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -84.91 162.52 19.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.1 OUTLIER -62.6 -24.5 67.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.483 ' HB2' ' HZ1' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -93.0 -49.05 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -163.22 -173.52 32.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.3 tttp -101.22 155.52 17.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 110.796 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 0.3 OUTLIER 61.12 57.65 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -170.92 26.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.801 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 7.7 mt -101.1 149.36 24.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.195 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.564 HG23 ' OE1' ' T' ' 18' ' ' GLU . 22.4 p -105.36 -160.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.288 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 43.1 t80 -82.38 -68.1 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 0.0 110.488 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.42 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.564 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.6 mt-10 -72.12 -52.38 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.146 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.85 -35.9 46.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.021 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.584 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 19.2 tttm -65.94 -53.55 37.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -61.23 -44.04 97.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.922 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -39.42 46.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.351 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.2 m -70.01 -58.58 3.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.411 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.1 mt-10 -57.35 -8.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.163 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 12.3 t80 -93.6 -49.99 5.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.253 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -77.49 9.23 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.313 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.08 69.17 1.37 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.769 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.7 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 171.07 -174.09 44.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.615 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -145.77 166.65 25.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 110.694 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.666 HD22 ' O ' ' T' ' 51' ' ' TRP . 17.6 mt -62.87 109.55 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -57.93 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 111.519 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.486 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -133.45 163.33 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.35 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.5 t80 -53.49 -53.4 51.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.691 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -52.16 -47.24 65.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.486 ' OE1' HG23 ' T' ' 32' ' ' THR . 64.2 mt-30 -59.46 -33.98 71.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.475 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -61.8 -39.01 90.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.81 -56.76 17.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.276 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.645 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -50.2 -29.74 10.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.223 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.528 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.61 -30.6 32.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.574 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -71.35 -36.78 71.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.736 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -59.33 -27.66 66.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.302 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.528 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -87.46 -17.01 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.92 44.23 1.43 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.23 75.22 9.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.895 0.379 . . . . 0.0 110.589 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.688 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 8.6 t-80 -82.8 136.91 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.181 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.484 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -175.98 113.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -75.45 -0.96 21.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -86.79 83.8 7.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.969 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -42.12 130.1 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' T' ' 57' ' ' VAL . . . -105.03 158.87 15.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.666 ' O ' HD22 ' T' ' 30' ' ' LEU . 88.1 m95 -93.58 137.55 32.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 110.973 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.407 ' O ' ' HE1' ' T' ' 16' ' ' TYR . 1.6 ptt? -137.53 -170.74 2.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.802 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.46 151.68 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.549 ' O ' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 68.71 -6.82 0.8 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 82.25 29.6 36.62 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.023 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' T' ' 56' ' ' ARG . 7.0 ttm180 -85.65 146.12 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.292 . . . . 0.0 110.692 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.85 157.35 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.292 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.81 162.94 29.15 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.982 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.969 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.4 p90 -136.44 95.35 12.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.661 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.2 Cg_endo -61.62 90.8 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.658 2.238 . . . . 0.0 111.816 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.797 HD11 ' HD2' ' T' ' 59' ' ' TYR . 8.5 mm -80.15 147.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.641 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.593 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 53.8 t -145.12 -23.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.622 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.484 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -119.92 78.76 24.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.782 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 27.8 Cg_endo -64.34 127.18 18.5 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.6 2.2 . . . . 0.0 112.351 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -93.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.281 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.63 -163.72 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 0.0 112.234 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -51.02 -21.21 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 1.5 m -66.53 -63.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -48.12 115.95 2.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.033 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.28 -10.57 59.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.01 -29.96 10.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.665 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -101.92 165.18 11.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p -113.31 127.67 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.265 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.4 169.14 12.42 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.009 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.76 HD11 ' HB3' ' T' ' 36' ' ' LEU . 6.4 mt -58.19 120.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.091 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.9 OUTLIER -95.23 86.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.892 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.16 112.47 17.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.41 7.99 10.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.64 28.32 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.901 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -50.35 145.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -110.95 16.75 21.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.901 ' H ' HG22 ' T' ' 80' ' ' ILE . 3.1 mm? 52.92 22.55 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' T' ' 85' ' ' SER . 27.0 t-20 -154.72 89.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.811 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.86 26.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.538 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -97.32 8.34 44.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -67.58 172.73 4.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -115.47 83.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.554 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.801 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 39.9 m95 -125.68 175.33 7.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.694 ' CG ' ' N ' ' T' ' 90' ' ' ALA . 0.0 OUTLIER -88.59 -170.1 2.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.427 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.694 ' N ' ' CG ' ' T' ' 89' ' ' ASP . . . -131.73 123.65 28.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.258 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.597 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 7.7 m-85 -85.68 73.96 10.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 6.3 m -54.64 159.28 2.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.623 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.6 t80 -152.93 126.28 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.163 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.7 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -163.88 118.51 1.08 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.135 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -4.02 6.83 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.507 2.138 . . . . 0.0 111.866 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -117.62 -10.04 10.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.01 55.38 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.11 129.48 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.222 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -126.98 162.65 25.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.992 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 139.86 35.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.938 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' T' ' 5' ' ' ARG . 12.2 mmt180 -145.99 147.46 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.606 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -104.09 -168.7 1.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.95 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.864 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.37 160.59 19.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.063 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 8' ' ' ARG . 16.7 mtm180 -65.15 -14.52 60.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 -29.46 11.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 162.38 173.27 30.86 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.421 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 23.6 ttpp -80.91 152.95 27.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.645 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 6.5 m-30 62.65 61.49 1.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.275 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.813 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -171.7 15.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.864 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -96.57 155.71 16.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.469 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.6 p -112.27 -160.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.477 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.752 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 66.7 t80 -83.51 -58.08 2.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 110.56 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.901 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.469 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.97 -52.61 13.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.253 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.7 -47.57 73.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.866 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.404 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 4.9 ttmt -58.01 -41.55 83.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.804 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.45 -43.71 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -51.61 -36.56 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' T' ' 26' ' ' GLU . 0.1 OUTLIER -77.03 -66.46 0.82 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.413 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.78 -27.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.261 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -87.44 -34.91 18.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' T' ' 23' ' ' CYS . 2.0 mt-10 -91.38 20.01 5.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.939 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.53 68.32 1.68 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.816 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.754 ' HA2' ' CG ' ' T' ' 94' ' ' ASN . . . 174.88 177.41 43.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.761 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -140.76 167.48 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.719 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.663 HD22 ' O ' ' T' ' 51' ' ' TRP . 33.9 mt -65.01 115.2 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.605 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.74 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.13 -165.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.112 0.482 . . . . 0.0 111.605 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.548 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -135.31 169.92 16.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.267 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.49 ' CE1' HG21 ' T' ' 75' ' ' ILE . 25.6 t80 -58.47 -54.16 50.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.671 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.31 -46.05 69.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.429 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.548 ' OE1' HG23 ' T' ' 32' ' ' THR . 76.7 mt-30 -60.62 -34.07 73.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.348 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.6 OUTLIER -64.35 -33.58 76.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.069 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.73 -57.66 9.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.332 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.58 -30.84 22.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.09 -29.73 63.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.267 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.49 61.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.509 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -50.93 -33.58 24.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.684 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -85.88 -33.36 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.802 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.684 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 125.55 47.69 0.21 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.242 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.9 t80 -84.98 81.04 9.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.807 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.665 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 9.5 t-80 -99.2 126.36 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.482 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -166.7 122.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.889 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -84.08 57.24 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.645 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -145.85 83.44 1.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -37.15 132.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.355 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -115.32 123.86 6.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.663 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.1 m95 -60.05 122.67 14.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -142.33 176.14 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.706 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.38 -163.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.287 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 mttp -46.31 -20.89 0.12 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.927 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.37 30.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.814 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' T' ' 52' ' ' MET . 5.7 ttm180 -83.28 131.77 35.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.779 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -113.11 144.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.956 0.408 . . . . 0.0 111.251 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -171.12 162.28 35.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.183 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.86 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.5 p90 -147.08 104.65 3.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.671 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 38.0 Cg_endo -68.72 112.99 3.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.619 2.212 . . . . 0.0 111.954 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.86 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.6 mm -108.48 98.66 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.441 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.5 -29.74 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.015 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -116.87 100.76 53.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 24.7 Cg_endo -63.43 155.24 63.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.302 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.07 -176.51 46.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.33 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.23 133.24 24.24 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.606 2.204 . . . . 0.0 112.232 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.48 28.72 12.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.31 -72.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -66.98 118.28 10.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.023 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.35 -5.69 55.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.94 -59.9 0.68 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.639 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -88.98 170.39 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 8.5 p -114.86 125.29 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.77 173.38 14.46 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.974 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.2 mt -55.49 120.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.632 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -95.23 86.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.983 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -120.99 109.28 14.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.161 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.37 -6.38 56.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.775 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.91 160.04 35.21 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.861 HG22 ' H ' ' T' ' 82' ' ' LEU . 12.7 mm -44.5 133.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' T' ' 81' ' ' ARG . 2.5 mmm180 -101.04 21.54 13.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.861 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.86 19.41 1.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.578 HD21 ' HB3' ' T' ' 85' ' ' SER . 38.2 t30 -158.36 98.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 4.6 ptt180 -78.77 33.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.578 ' HB3' HD21 ' T' ' 83' ' ' ASN . 22.1 t -111.25 19.52 18.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 1.1 mm-40 -74.64 174.58 8.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.813 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -113.21 90.97 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.528 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.779 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.0 m95 -127.93 -145.83 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.085 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.614 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.5 m-20 -123.54 -137.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.2 118.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.833 0.349 . . . . 0.0 111.433 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.671 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -85.57 73.29 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.827 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.626 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.9 OUTLIER -49.13 159.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.566 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.8 OUTLIER -156.4 130.26 8.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.376 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.754 ' CG ' ' HA2' ' T' ' 28' ' ' GLY . 0.8 OUTLIER -170.14 120.65 0.56 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.942 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.51 -3.12 9.56 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.458 2.106 . . . . 0.0 111.962 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -116.23 -14.9 11.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.57 56.58 4.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.048 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 tttt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.888 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.727 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -86.05 125.73 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 111.342 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -123.69 156.13 36.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 110.96 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 34.2 t60 -107.81 126.7 52.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.18 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.3 OUTLIER -129.92 162.3 28.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.798 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.562 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -111.84 -167.49 1.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.065 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.69 152.98 24.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -67.06 -15.93 64.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 93.7 p -96.13 -17.57 20.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 156.67 173.91 25.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.281 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 3.2 tppt? -58.92 146.81 36.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.784 0.326 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 57.7 m-85 54.06 -151.62 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 9.6 mttt 67.81 11.69 8.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.164 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 10.5 mt -98.26 150.88 21.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.474 HG23 ' OE1' ' T' ' 18' ' ' GLU . 43.0 p -105.84 -158.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.229 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.45 -61.53 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.398 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -30.61 70.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.474 ' OE1' HG23 ' T' ' 15' ' ' THR . 82.5 mt-10 -72.71 -54.64 8.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -50.48 -37.84 40.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 7.3 tttt -64.22 -52.44 58.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.83 96.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.02 -38.83 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.093 0.473 . . . . 0.0 110.434 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -69.54 -60.73 2.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.36 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -54.14 -15.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -88.35 -31.7 18.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -93.17 13.76 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 80.6 64.66 1.8 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.033 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.773 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.87 -168.32 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -150.34 170.6 18.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.703 HD22 ' O ' ' T' ' 51' ' ' TRP . 31.9 mt -64.21 108.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.641 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.36 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.102 0.477 . . . . 0.0 111.427 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.58 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.51 168.59 16.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.266 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' T' ' 75' ' ' ILE . 16.5 t80 -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -56.24 -47.42 78.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.509 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.58 ' OE1' HG23 ' T' ' 32' ' ' THR . 75.8 mt-30 -58.92 -36.82 75.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.2 OUTLIER -65.14 -29.64 70.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.015 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 5.1 tp10 -63.58 -57.25 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.997 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -53.14 -30.91 39.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.029 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.538 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -71.21 -30.4 66.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.317 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -70.74 -34.95 72.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 8.3 mttp -57.7 -23.36 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.323 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.538 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.1 pp -95.48 -15.57 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.939 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 42.31 1.7 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.072 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -89.83 80.93 6.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 0.0 110.634 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.759 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -106.56 131.38 53.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.206 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -161.26 123.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.567 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.615 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -71.68 13.59 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.809 -179.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.665 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -104.81 119.63 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.815 0.34 . . . . 0.0 110.563 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.786 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -70.33 119.19 14.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.252 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -94.44 118.48 5.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.833 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.703 ' O ' HD22 ' T' ' 30' ' ' LEU . 77.4 m95 -59.08 118.24 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.6 ptt? -142.28 -179.32 6.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . 45.33 -163.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.319 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -50.89 -9.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 140.54 30.79 0.17 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 2.6 ttm105 -85.48 132.38 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.287 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -117.3 142.33 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 111.3 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -165.53 161.92 35.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.899 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.11 103.76 6.73 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.331 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_endo -67.53 102.97 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.584 2.19 . . . . 0.0 111.849 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.899 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.3 mm -94.92 96.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.597 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' T' ' 45' ' ' HIS . 17.1 t -93.67 -29.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 10.2 tmtt? -111.84 82.73 4.19 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.59 164.43 28.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.555 2.17 . . . . 0.0 112.364 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.64 -97.4 0.12 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.187 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 71.9 Cg_endo -75.2 -145.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.593 2.196 . . . . 0.0 112.243 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 45.3 t30 -52.25 -21.98 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.68 -57.85 9.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.95 110.7 1.03 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.941 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.17 -12.03 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.36 -56.07 0.75 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.696 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -98.7 167.14 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.21 126.2 54.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.176 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.71 176.54 15.35 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.7 mt -56.51 117.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.956 0.407 . . . . 0.0 111.029 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.887 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -95.93 86.6 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.032 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 0.1 OUTLIER -124.73 133.35 53.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.62 27.79 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 58.67 179.55 1.17 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.7 mm -49.36 125.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -85.71 10.04 14.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.582 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 58.45 31.66 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.79 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.576 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 41.3 t30 -160.92 94.39 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.513 ' NE ' ' H ' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -70.07 27.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.077 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.535 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -116.76 2.86 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.269 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.8 mm-40 -61.24 166.14 3.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -109.02 111.86 23.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.769 ' CD2' ' HB3' ' T' ' 49' ' ' ALA . 35.5 m95 -151.48 -165.96 2.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.713 ' HA ' HD12 ' T' ' 14' ' ' LEU . 1.6 m-20 -109.59 -134.15 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.923 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.546 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -169.88 127.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.026 0.441 . . . . 0.0 111.787 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 10.8 m-85 -91.92 73.34 5.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.561 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.611 ' N ' ' O ' ' T' ' 3' ' ' TYR . 84.8 m -49.95 170.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.392 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.779 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -165.29 128.54 2.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.384 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.773 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 50.8 t-20 -168.76 119.21 0.63 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.757 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.95 0.37 5.12 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.533 2.155 . . . . 0.0 112.068 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -118.51 -6.66 10.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.02 55.44 2.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . 0.413 ' H ' ' HG3' ' T' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.893 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.62 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.6 OUTLIER -83.91 125.96 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.77 0.319 . . . . 0.0 111.316 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -124.98 165.78 17.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.07 144.54 25.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.856 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -146.39 139.05 25.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.657 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -106.66 -168.08 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.626 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.14 155.74 18.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -16.39 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.6 p -97.49 -16.66 20.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 153.65 172.6 21.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.277 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 9.0 ttmm -58.4 148.13 28.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' T' ' 88' ' ' TRP . 47.3 m-85 58.28 -154.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 3.2 mttm 65.43 10.26 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' T' ' 89' ' ' ASP . 9.9 mt -94.25 144.7 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.9 0.381 . . . . 0.0 111.089 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . . . . . . . . . 62.6 p -99.26 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.297 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 56.5 t80 -83.34 -57.27 3.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.961 0.41 . . . . 0.0 110.543 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.1 -29.62 70.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.029 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -75.34 -50.32 16.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -54.03 -45.55 71.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.89 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.57 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -62.41 -49.13 76.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -45.23 94.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 t -51.73 -38.49 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.242 0.544 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' T' ' 25' ' ' PHE . 17.1 m -74.5 -64.85 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 0.7 OUTLIER -54.45 -8.61 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.406 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' T' ' 23' ' ' CYS . 87.0 t80 -83.37 -34.62 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.457 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.44 -62.24 1.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.94 75.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.905 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . 157.53 -166.13 33.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.604 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.573 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -147.36 178.02 8.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.695 0.283 . . . . 0.0 110.62 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.709 HD22 ' O ' ' T' ' 51' ' ' TRP . 27.7 mt -63.95 111.85 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.666 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -58.43 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.459 . . . . 0.0 111.386 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.632 HG23 ' OE1' ' T' ' 35' ' ' GLN . 1.1 p -124.6 165.87 17.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.8 t80 -56.53 -52.71 63.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.68 -47.13 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.914 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.632 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.0 mt-30 -56.03 -35.26 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' T' ' 91' ' ' TYR . 0.3 OUTLIER -66.05 -41.1 91.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -65.27 -52.35 54.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.375 0.607 . . . . 0.0 110.144 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.89 -28.9 25.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.6 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.38 -32.27 17.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.068 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.885 ' HG3' ' HB2' ' T' ' 60' ' ' PRO . 0.0 OUTLIER -76.09 -36.9 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.246 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' T' ' 42' ' ' ILE . 7.9 ptmt -53.57 -29.84 39.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.856 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.522 HG13 ' N ' ' T' ' 43' ' ' GLY . 0.8 OUTLIER -83.58 -26.67 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.522 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 158.47 -26.74 0.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.881 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.639 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.1 t80 -46.67 92.02 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.831 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.1 OUTLIER -122.87 119.08 29.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.929 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.891 HG12 ' H ' ' T' ' 48' ' ' ALA . 59.5 t -147.35 128.25 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -79.02 8.7 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.178 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.891 ' H ' HG12 ' T' ' 46' ' ' VAL . . . -101.21 97.79 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -51.24 118.29 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.28 125.35 8.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.916 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.709 ' O ' HD22 ' T' ' 30' ' ' LEU . 90.1 m95 -57.85 145.64 34.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.344 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 2.3 ptt? -145.4 -169.62 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.75 150.41 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.28 -11.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 88.02 26.45 28.86 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.806 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' T' ' 52' ' ' MET . 8.8 ttm180 -81.02 145.73 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.702 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.738 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -129.73 145.47 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.979 0.419 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.39 161.17 30.12 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.119 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.2 OUTLIER -131.66 103.02 14.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.913 0.387 . . . . 0.0 111.205 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.885 ' HB2' ' HG3' ' T' ' 40' ' ' ARG . 33.3 Cg_endo -66.7 85.86 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.655 2.236 . . . . 0.0 111.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.925 HD11 ' HD2' ' T' ' 59' ' ' TYR . 9.8 mm -74.32 151.37 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 3.5 t -149.98 -32.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.422 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 9.3 tmtt? -119.81 85.64 34.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 169.14 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.644 2.229 . . . . 0.0 112.397 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.64 -139.73 2.72 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.178 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.25 -8.79 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.554 2.169 . . . . 0.0 112.565 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.13 46.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.96 -64.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.843 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -78.72 133.46 12.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.945 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.98 6.35 29.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.82 -31.17 7.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.674 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -108.36 165.36 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 0.0 110.948 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . 0.573 HG22 ' HA ' ' T' ' 62' ' ' VAL . 6.2 p -110.61 127.09 55.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.552 ' HA2' ' NH1' ' T' ' 40' ' ' ARG . . . 150.8 168.61 15.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.904 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.793 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 7.6 mt -61.42 124.85 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -100.0 86.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.78 125.57 40.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.56 10.04 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 78.88 166.35 30.7 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.746 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mm -46.39 132.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.807 0.337 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' T' ' 81' ' ' ARG . 3.2 mmm180 -96.31 25.24 5.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.068 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.746 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.98 15.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -152.91 98.72 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.731 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.754 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -79.26 28.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.6 m -114.3 19.93 15.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.88 168.19 20.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -98.28 115.0 27.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.722 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.738 ' NE1' HG21 ' T' ' 57' ' ' VAL . 26.6 m95 -155.06 -169.12 3.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.71 ' HA ' HD12 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -99.78 -141.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.324 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -166.25 115.93 0.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.665 ' CB ' HD21 ' T' ' 36' ' ' LEU . 16.3 m-85 -86.53 75.72 9.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.207 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG23 ' T' ' 2' ' ' VAL . 99.9 m -47.26 162.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.328 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.754 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 2.3 t80 -156.15 132.92 10.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.233 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.929 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 20.7 t-20 -167.72 120.62 0.75 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -25.05 74.06 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.811 2.34 . . . . 0.0 112.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -101.04 6.11 43.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.795 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.929 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -81.43 46.69 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.134 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -76.72 128.97 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.271 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -119.53 149.57 41.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 110.875 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.579 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 23.6 t-80 -84.6 142.58 29.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.072 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -140.82 154.82 46.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.504 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -101.04 -167.04 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -101.63 164.23 11.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -20.19 53.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.0 -47.31 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 172.5 -168.33 41.37 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.341 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.4 ttpt -66.18 139.61 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.313 . . . . 0.0 110.85 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.701 ' HE1' ' HA ' ' T' ' 48' ' ' ALA . 12.6 m-30 55.07 62.62 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.618 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 10.1 mmtt -147.2 -8.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.486 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.856 HD11 ' O ' ' T' ' 89' ' ' ASP . 2.6 pp -100.48 168.83 9.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.122 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.624 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 13.2 p -118.86 -154.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 87.2 t80 -82.54 -52.71 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.025 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.2 73.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.095 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HB2' ' H ' ' T' ' 15' ' ' THR . 27.6 mt-10 -72.73 -59.3 2.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.85 -43.1 13.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.461 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.2 tttp -61.6 -47.14 86.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.97 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.3 -44.99 95.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.06 -39.31 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.077 0.465 . . . . 0.0 110.34 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' T' ' 30' ' ' LEU . 1.3 m -70.59 -59.66 2.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.456 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 mt-10 -58.03 -8.52 1.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.994 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -80.86 -33.06 34.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.102 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.44 -2.92 57.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.724 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 99.59 18.82 22.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.037 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -130.99 -164.53 11.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.785 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 172.21 13.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.756 0.312 . . . . 0.0 110.747 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' T' ' 20' ' ' LYS . 24.9 mt -66.57 125.94 27.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -63.94 -165.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.095 0.474 . . . . 0.0 111.198 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.646 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -136.51 167.28 21.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.305 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.523 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.1 t80 -55.19 -52.08 64.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.81 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -49.13 74.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.659 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.646 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.1 mt-30 -59.17 -36.55 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.578 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -32.87 74.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.095 0.474 . . . . 0.0 110.254 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -64.21 -57.43 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.285 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.06 -30.15 14.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.124 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -80.0 -30.29 39.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.54 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.69 -35.92 75.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.1 OUTLIER -64.63 -25.56 68.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.133 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.558 HG13 ' O ' ' T' ' 39' ' ' ALA . 0.9 OUTLIER -85.73 -18.02 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.8 42.06 0.96 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.116 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.548 ' HD2' ' HB1' ' T' ' 39' ' ' ALA . 1.1 t80 -92.93 77.79 4.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.675 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.766 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 2.3 t-80 -103.22 134.33 46.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.988 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.579 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -170.27 137.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.518 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -91.96 61.46 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.701 ' HA ' ' HE1' ' T' ' 12' ' ' TYR . . . -153.75 90.59 1.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.793 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -45.23 134.23 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.387 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.496 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -111.5 130.08 9.52 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.649 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.725 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.1 m95 -67.05 117.87 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 110.818 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -117.08 -171.61 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.58 154.74 1.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.253 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.545 ' O ' HD12 ' T' ' 80' ' ' ILE . 3.7 mttm 66.32 -2.15 1.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 78.63 26.97 57.98 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.055 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.54 ' HA ' HD13 ' T' ' 80' ' ' ILE . 28.1 ttm180 -81.52 152.54 27.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.675 0.274 . . . . 0.0 110.513 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.682 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.8 OUTLIER -135.29 145.49 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.434 . . . . 0.0 111.564 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.776 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.72 158.2 27.1 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.976 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.856 ' HD2' HD11 ' T' ' 61' ' ' ILE . 1.9 p90 -138.34 102.93 7.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.901 0.382 . . . . 0.0 111.433 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 34.7 Cg_endo -67.26 110.14 1.94 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.616 2.211 . . . . 0.0 111.866 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.856 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.4 mm -105.07 98.98 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.553 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' T' ' 45' ' ' HIS . 6.3 t -86.72 -28.44 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 1.1 tttm -120.86 90.73 46.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 47.5 Cg_exo -54.15 161.56 5.03 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.648 2.232 . . . . 0.0 112.305 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' T' ' 69' ' ' GLY . . . -177.7 -166.56 34.51 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.277 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.28 124.13 9.72 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.515 2.143 . . . . 0.0 112.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 58.47 24.18 11.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 30.4 t -132.67 -74.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -64.02 116.09 8.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.913 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -79.03 3.07 18.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 110.85 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.91 -47.26 1.05 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.583 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.81 165.12 12.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 79.5 p -114.15 126.92 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.81 175.33 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 4.3 mt -55.78 116.85 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.712 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -94.46 85.63 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.466 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.0 OUTLIER -127.32 123.34 36.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.2 14.47 14.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.14 166.8 19.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.833 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.5 mm -52.57 135.97 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.18 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.869 ' HD2' ' HB2' ' T' ' 83' ' ' ASN . 0.0 OUTLIER -105.65 8.84 33.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.833 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 75.53 -26.21 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.287 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.869 ' HB2' ' HD2' ' T' ' 81' ' ' ARG . 0.4 OUTLIER -99.2 89.25 4.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.865 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 0.0 OUTLIER -76.76 24.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.426 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -111.52 1.59 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.5 mm-40 -57.98 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.618 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -101.34 104.43 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.315 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.741 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.3 m95 -134.95 -150.33 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.856 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.7 OUTLIER -118.17 -149.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.884 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -165.97 119.67 1.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.943 0.402 . . . . 0.0 111.66 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.579 ' OH ' HG13 ' T' ' 46' ' ' VAL . 47.3 m-85 -91.84 76.91 5.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.513 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.603 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.3 m -47.01 164.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.4 OUTLIER -155.9 120.92 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.272 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.566 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 31.9 t30 -172.08 110.34 0.37 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 37.1 Cg_endo -66.53 1.34 2.68 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.658 2.239 . . . . 0.0 112.371 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -125.17 6.79 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -85.67 55.83 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.4 OUTLIER -83.25 128.02 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.483 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -125.26 160.14 29.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' T' ' 91' ' ' TYR . 30.9 t60 -108.97 135.29 50.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.415 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.1 OUTLIER -140.4 162.44 35.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.654 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.703 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 2.2 pm0 -105.37 -168.97 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.732 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -79.81 145.69 32.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.956 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -52.11 -23.76 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.31 -48.6 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -167.47 -178.01 39.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.464 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.4 tttt -90.03 156.05 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.423 ' H ' ' HG3' ' T' ' 11' ' ' LYS . 1.8 m-30 53.26 69.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.108 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -178.85 36.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.658 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.732 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.0 mt -111.94 151.61 29.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.444 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.492 HG23 ' OE1' ' T' ' 18' ' ' GLU . 72.8 p -108.25 -159.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.289 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.53 -56.25 3.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.07 70.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.923 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' T' ' 15' ' ' THR . 81.8 mt-10 -73.64 -46.76 44.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.612 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' T' ' 51' ' ' TRP . . . -55.54 -41.24 72.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.059 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 17.5 ttpp -64.55 -50.29 67.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.006 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.35 84.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.51 -37.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.221 0.534 . . . . 0.0 110.355 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.5 -60.42 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.387 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 1.9 tt0 -57.14 -11.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -86.88 -29.84 21.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.985 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.75 1.37 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.024 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 95.36 63.17 0.98 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.1 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.795 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 176.43 -168.38 40.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.6 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -150.82 171.39 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.671 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.4 mt -63.5 108.63 1.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.626 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.726 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.51 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.42 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.621 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -131.76 158.88 40.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.274 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' T' ' 75' ' ' ILE . 18.4 t80 -50.42 -50.51 51.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.764 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.73 -47.55 76.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.654 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' T' ' 32' ' ' THR . 91.7 mt-30 -60.26 -35.3 75.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.662 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -64.87 -30.87 71.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.224 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -66.54 -57.69 6.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.185 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.583 ' O ' ' HG2' ' T' ' 41' ' ' LYS . . . -51.07 -30.41 15.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.166 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG13 ' T' ' 42' ' ' ILE . . . -81.53 -30.95 32.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.551 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -67.99 -35.66 78.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' T' ' 38' ' ' ALA . 0.0 OUTLIER -67.54 -25.13 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.336 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.574 HG13 ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -84.41 -16.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.402 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.41 41.03 0.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.965 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -94.44 74.14 3.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.688 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 5.5 t-80 -98.16 119.63 37.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.342 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 1.0 OUTLIER -149.62 118.07 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.865 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.659 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.07 6.18 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.046 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.16 116.57 32.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.187 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.828 ' HB1' HG13 ' T' ' 57' ' ' VAL . . . -63.32 130.96 46.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.426 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.95 130.34 9.87 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.607 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.671 ' O ' HD22 ' T' ' 30' ' ' LEU . 70.3 m95 -72.89 134.75 44.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 0.0 111.188 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.591 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 2.8 ptt? -137.66 -168.76 2.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.72 156.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.347 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.01 -2.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.485 ' C ' HD12 ' T' ' 80' ' ' ILE . . . 76.65 29.67 57.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.702 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' T' ' 52' ' ' MET . 25.5 ttm-85 -81.05 130.1 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.691 0.281 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.828 HG13 ' HB1' ' T' ' 49' ' ' ALA . 0.9 OUTLIER -120.46 128.76 76.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 111.319 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.832 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -161.72 165.71 35.8 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.104 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.853 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.6 OUTLIER -134.75 107.32 10.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.317 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 35.6 Cg_endo -67.39 106.97 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.633 2.222 . . . . 0.0 111.694 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.954 HG12 HG13 ' T' ' 76' ' ' ILE . 4.4 mm -101.07 95.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 5.9 t -86.58 -25.31 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 12.9 tttp -117.8 90.88 37.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.656 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 50.4 Cg_exo -53.58 154.62 15.3 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.654 2.236 . . . . 0.0 112.382 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.412 ' H ' ' HA3' ' T' ' 69' ' ' GLY . . . 171.79 174.84 39.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.41 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 138.42 38.63 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.62 2.213 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 59.53 24.74 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.29 -76.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.86 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -72.02 124.03 9.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.986 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.56 -3.28 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.15 -31.33 6.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.74 163.3 12.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -112.42 117.51 32.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.167 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.98 172.54 16.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.014 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.824 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 3.6 mt -59.56 124.04 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 111.042 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.954 HG13 HG12 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -97.66 85.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.957 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.832 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 0.3 OUTLIER -133.53 118.7 18.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.08 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.92 30.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.05 178.57 8.56 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.641 HG22 ' H ' ' T' ' 82' ' ' LEU . 4.4 mm -48.41 109.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -58.58 -2.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.641 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.8 OUTLIER 60.69 13.55 4.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.836 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' T' ' 86' ' ' GLU . 39.8 t30 -158.25 89.79 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.711 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.436 ' HA ' ' CH2' ' T' ' 51' ' ' TRP . 2.2 ptt85 -67.36 16.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.536 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -88.3 7.29 32.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.877 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 34.2 mm-40 -72.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.62 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 82.2 mtt180 -135.07 90.88 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.596 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.682 ' CD1' HG11 ' T' ' 57' ' ' VAL . 77.4 m95 -128.53 -152.67 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.121 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' T' ' 4' ' ' HIS . 1.2 m-20 -122.57 -136.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' H ' ' T' ' 51' ' ' TRP . . . -168.81 137.05 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.756 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' T' ' 4' ' ' HIS . 13.7 m-85 -98.45 75.07 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' T' ' 3' ' ' TYR . 79.2 m -49.54 169.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.579 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -163.39 128.28 2.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.36 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.795 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 52.3 t-20 -168.7 120.26 0.66 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.29 -3.02 10.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.586 2.191 . . . . 0.0 112.208 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -121.1 8.74 10.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.684 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -84.6 48.06 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.638 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.3 129.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.791 0.329 . . . . 0.0 111.215 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -126.49 165.66 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -112.39 134.61 53.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 4.4 mmt180 -141.79 154.25 45.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -101.16 -169.08 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.008 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -60.71 -176.35 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.307 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -45.99 -40.59 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.033 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 87.1 p -157.45 -5.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.28 163.64 14.96 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.277 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -109.98 145.1 37.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.687 0.28 . . . . 0.0 111.22 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 34.3 m-85 49.33 75.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.925 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -173.64 25.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.097 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.638 HD21 ' HA ' ' T' ' 7' ' ' ALA . 23.4 mt -102.86 151.39 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.439 HG23 ' OE1' ' T' ' 18' ' ' GLU . 38.3 p -107.65 -158.64 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.412 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.817 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 52.1 t80 -82.09 -62.52 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 110.492 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.66 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.982 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' T' ' 15' ' ' THR . 80.4 mt-10 -71.97 -59.88 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.033 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.09 -44.03 15.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.917 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.573 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 11.8 tttt -61.4 -43.73 98.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.21 64.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -34.65 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.447 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 2.0 m -67.9 -61.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.469 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 17.7 mt-10 -58.07 -8.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -90.19 -48.98 6.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.838 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.37 2.22 22.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.232 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.648 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 92.5 68.22 1.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.968 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.746 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 171.38 -173.52 44.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.574 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 8.4 p-80 -147.35 168.51 21.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.996 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.625 HD22 ' O ' ' T' ' 51' ' ' TRP . 24.0 mt -60.85 106.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.658 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.75 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.24 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.077 0.465 . . . . 0.0 111.411 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.482 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.0 OUTLIER -130.5 162.39 29.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.225 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' T' ' 75' ' ' ILE . 33.9 t80 -52.71 -54.33 35.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -51.49 -46.75 63.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.359 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.482 ' CD ' HG23 ' T' ' 32' ' ' THR . 64.6 mt-30 -60.63 -35.19 75.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.222 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.573 ' CD1' ' HG3' ' T' ' 60' ' ' PRO . 0.1 OUTLIER -64.87 -32.3 73.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.96 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -62.61 -57.64 10.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.158 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.58 35.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -29.55 65.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.131 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -35.36 67.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.408 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -50.8 -35.84 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.527 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -84.68 -28.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.825 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.527 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 117.47 47.28 0.46 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.374 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -70.68 82.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.341 . . . . 0.0 110.697 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 22.7 t-160 -85.32 114.91 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.412 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.1 OUTLIER -162.72 114.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 1.72 40.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' T' ' 12' ' ' TYR . . . -96.84 95.37 7.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.387 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.761 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.32 132.58 5.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.366 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.5 122.45 5.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.625 ' O ' HD22 ' T' ' 30' ' ' LEU . 87.0 m95 -55.47 143.23 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.986 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -143.93 -169.56 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.81 151.86 3.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 9.6 mtpt 68.44 -12.07 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.568 ' HA3' ' HE ' ' T' ' 84' ' ' ARG . . . 87.39 31.55 16.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.819 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.66 150.93 23.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.703 0.287 . . . . 0.0 110.661 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.675 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.5 m -132.85 141.68 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -169.9 165.21 38.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.967 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.77 ' HD2' HD11 ' T' ' 61' ' ' ILE . 3.2 p90 -143.27 94.34 6.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.625 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 25.6 Cg_endo -63.47 112.27 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.483 2.122 . . . . 0.0 111.578 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.2 OUTLIER -109.65 124.89 66.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.37 -23.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.736 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.623 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -119.55 97.69 50.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.72 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 18.8 Cg_endo -60.6 145.96 97.9 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.308 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 179.01 173.74 44.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.088 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.52 131.25 44.55 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.522 2.148 . . . . 0.0 112.18 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.61 29.82 19.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.77 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 10.7 t -162.93 89.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.23 131.86 4.79 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.915 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -1.07 33.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.91 5.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.684 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -99.55 157.77 16.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 56.8 p -112.65 125.49 54.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.214 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.23 172.91 15.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.979 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -57.29 116.15 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.549 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -94.62 86.75 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.38 113.66 16.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.58 14.4 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.63 166.0 22.97 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.82 HG22 ' H ' ' T' ' 82' ' ' LEU . 2.2 mm -50.79 140.21 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 111.128 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -95.31 16.45 16.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.82 ' H ' HG22 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 58.37 16.12 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.8 OUTLIER -163.08 110.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.817 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 35.5 mmt-85 -75.02 22.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.446 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -91.84 5.28 50.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.078 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -73.05 164.13 27.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.925 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 8.3 ptt180 -109.28 121.23 44.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.675 ' NE1' HG21 ' T' ' 57' ' ' VAL . 38.9 m95 -155.63 -146.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.0 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.56 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 1.0 OUTLIER -119.42 -136.32 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.127 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.01 121.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.911 0.386 . . . . 0.0 111.332 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.665 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 10.2 m-85 -88.09 73.46 9.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.543 ' O ' HG23 ' T' ' 2' ' ' VAL . 87.3 m -55.62 169.66 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -160.94 127.44 4.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.421 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.746 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 47.3 t-20 -168.67 119.3 0.64 Allowed Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.36 2.23 2.96 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.558 2.172 . . . . 0.0 112.077 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -119.64 -6.9 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.489 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.02 55.04 2.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.569 HG23 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER -71.25 133.63 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 111.145 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -130.36 168.68 16.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 145.44 26.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -147.92 146.4 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -100.37 -169.33 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.597 ' HA ' HD21 ' T' ' 14' ' ' LEU . . . -67.16 -175.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.354 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -55.46 -33.47 63.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.61 49.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.51 164.33 29.82 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.414 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' T' ' 12' ' ' TYR . 0.1 OUTLIER -109.17 161.75 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.833 0.349 . . . . 0.0 111.157 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' T' ' 11' ' ' LYS . 3.2 m-30 45.8 69.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -179.0 30.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 10.2 mt -110.08 150.46 28.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.484 HG23 ' OE1' ' T' ' 18' ' ' GLU . 26.6 p -106.6 -160.12 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' T' ' 84' ' ' ARG . 56.2 t80 -84.05 -61.61 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.37 . . . . 0.0 110.622 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.37 -30.9 67.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.873 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.484 ' OE1' HG23 ' T' ' 15' ' ' THR . 79.8 mt-10 -74.2 -52.61 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.404 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.53 -40.12 65.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.903 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 8.1 tttp -62.45 -50.01 73.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.771 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -45.68 90.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.563 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.23 -36.14 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.418 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' T' ' 30' ' ' LEU . 5.4 m -70.03 -62.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.556 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 3.8 mt-10 -56.61 -8.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.917 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' T' ' 23' ' ' CYS . 82.9 t80 -80.76 -32.65 35.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.188 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.21 1.7 56.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 94.77 19.31 32.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.059 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -132.17 -167.29 11.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.783 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -145.99 168.41 20.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.731 0.301 . . . . 0.0 110.94 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.688 HD22 ' O ' ' T' ' 51' ' ' TRP . 32.5 mt -61.97 113.16 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.01 -164.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.165 0.507 . . . . 0.0 111.506 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.698 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 0.8 OUTLIER -136.2 -171.33 2.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.41 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' T' ' 36' ' ' LEU . 2.8 t80 -68.78 -69.71 0.31 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.911 0.863 . . . . 0.0 109.709 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -41.09 -47.72 3.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.013 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.698 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 31.5 mt-30 -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.999 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.768 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.4 OUTLIER -63.82 -30.82 71.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.931 179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 20.1 tt0 -63.24 -57.58 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.08 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.35 -31.56 22.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.942 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -71.42 -30.19 65.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.202 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -73.16 -35.72 66.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.496 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.521 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 4.3 mtpt -52.25 -33.71 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.097 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.478 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -85.46 -26.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.878 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.478 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 118.07 45.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.289 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -81.23 85.62 6.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.738 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.605 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 10.6 t-160 -99.35 116.46 31.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.642 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -158.37 121.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -82.13 -1.38 48.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.029 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.642 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -88.45 85.23 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.622 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.896 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -39.77 130.72 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.434 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.17 128.45 9.13 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.708 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.688 ' O ' HD22 ' T' ' 30' ' ' LEU . 81.8 m95 -61.98 125.7 24.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -145.24 179.81 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.873 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.412 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 45.08 -163.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.25 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -14.83 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.47 30.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.814 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.0 OUTLIER -85.81 135.01 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.716 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.6 OUTLIER -113.81 143.31 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.183 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.85 162.86 36.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.164 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.896 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 1.5 p90 -140.4 100.07 6.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.855 0.359 . . . . 0.0 111.374 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.74 ' HG3' HD12 ' T' ' 36' ' ' LEU . 29.2 Cg_endo -65.0 98.49 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.57 2.18 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' T' ' 59' ' ' TYR . 5.5 mm -92.74 111.28 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.519 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 17.6 t -92.8 -28.06 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.818 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.473 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 2.0 tmtm? -119.42 100.09 49.83 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.622 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 12.2 Cg_endo -57.4 156.79 24.54 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.746 2.297 . . . . 0.0 112.278 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' T' ' 67' ' ' ASN . . . -157.73 172.05 34.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.31 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' T' ' 67' ' ' ASN . 8.5 Cg_exo -72.13 36.7 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.026 2.484 . . . . 0.0 112.405 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' T' ' 66' ' ' PRO . 23.8 t30 175.87 -45.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.938 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.41 -64.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . -60.62 114.77 6.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -2.07 43.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.868 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.97 -87.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.733 . . . . 0.0 111.644 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -87.28 -171.1 3.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -111.97 124.19 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.06 178.98 33.57 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.017 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' T' ' 36' ' ' LEU . 7.7 mt -68.24 121.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.016 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.563 HG13 ' CD2' ' T' ' 59' ' ' TYR . 1.0 OUTLIER -91.69 87.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.27 109.6 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.76 8.16 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 165.21 30.19 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.866 HG22 ' H ' ' T' ' 82' ' ' LEU . 3.1 mm -49.34 143.26 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -102.51 15.93 27.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.018 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.866 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.6 OUTLIER 54.09 23.9 4.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.75 HD21 ' HB3' ' T' ' 85' ' ' SER . 33.6 t30 -163.21 98.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.67 ' HB3' ' HB2' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -70.44 18.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.251 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.75 ' HB3' HD21 ' T' ' 83' ' ' ASN . 20.9 t -91.36 5.81 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' T' ' 83' ' ' ASN . 1.7 mm-40 -62.94 169.81 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.836 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 49.3 mtt85 -116.09 88.13 2.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.716 ' NE1' HG21 ' T' ' 57' ' ' VAL . 44.3 m95 -126.84 -162.59 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.15 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.578 ' O ' ' HD1' ' T' ' 51' ' ' TRP . 0.7 OUTLIER -106.34 -137.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.509 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.99 117.32 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.957 0.408 . . . . 0.0 111.411 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.613 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.2 m-85 -88.97 75.02 8.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.569 ' O ' HG23 ' T' ' 2' ' ' VAL . 80.9 m -60.35 171.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.7 OUTLIER -154.44 121.8 5.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.278 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' T' ' 97' ' ' ALA . 30.1 t30 -170.18 110.39 0.45 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.734 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 25.9 Cg_endo -62.63 -3.13 4.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.316 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -115.67 -8.87 12.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.519 ' HB2' ' ND2' ' T' ' 94' ' ' ASN . . . -82.38 55.94 3.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -84.98 136.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 0.0 111.402 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -136.21 156.56 48.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.147 0.498 . . . . 0.0 110.968 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.625 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 27.2 t60 -110.27 126.06 53.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.224 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' T' ' 89' ' ' ASP . 0.0 OUTLIER -126.62 170.23 12.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.886 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -103.06 -165.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -78.08 -172.4 2.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.507 HH11 ' HB2' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -51.54 -36.87 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.8 7.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.02 164.96 12.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.43 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -106.21 142.12 36.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.73 0.3 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' T' ' 48' ' ' ALA . 23.4 m-85 43.06 63.48 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -155.03 21.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' T' ' 88' ' ' TRP . 6.7 mt -98.58 155.62 17.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.412 HG23 ' OE1' ' T' ' 18' ' ' GLU . 31.1 p -114.33 -161.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.61 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 71.7 t80 -84.95 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.572 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.9 -29.69 70.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.9 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' T' ' 15' ' ' THR . 78.8 mt-10 -76.28 -55.01 5.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' T' ' 22' ' ' VAL . . . -49.89 -51.33 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' T' ' 24' ' ' GLU . 4.3 ttmm -56.77 -47.99 78.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.086 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.62 76.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' T' ' 19' ' ' ALA . 1.4 t -55.99 -41.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 110.212 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -61.94 1.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.385 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' T' ' 20' ' ' LYS . 23.8 mt-10 -53.78 -15.36 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.268 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.71 -34.05 19.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.751 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.05 -12.7 24.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 106.18 66.77 0.66 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.019 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.649 ' HA2' HD21 ' T' ' 94' ' ' ASN . . . 176.81 -168.64 40.71 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.663 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -146.86 171.06 15.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' T' ' 52' ' ' MET . 18.2 mt -68.22 124.01 22.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.552 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -60.18 -166.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.611 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.98 163.66 29.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.337 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' T' ' 75' ' ' ILE . 31.6 t80 -52.65 -55.06 25.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -46.68 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.399 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.611 ' CD ' HG23 ' T' ' 32' ' ' THR . 32.4 mt-30 -59.64 -33.44 71.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.464 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.4 OUTLIER -65.32 -32.28 73.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.15 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -65.29 -57.68 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.301 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.22 -30.84 29.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 -29.76 60.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.459 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.75 -35.86 65.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.714 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -51.63 -29.46 17.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.217 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.669 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -89.04 -33.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.669 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 128.14 41.18 0.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.947 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -94.95 88.84 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.589 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -120.28 135.75 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 111.266 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.722 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -154.54 119.29 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.183 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -63.42 3.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.809 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.722 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -101.76 123.18 45.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 110.126 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.81 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -65.49 143.74 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -118.31 117.08 3.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.644 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' T' ' 89' ' ' ASP . 85.8 m95 -59.78 115.62 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.01 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 1.3 ptt? -141.36 177.44 8.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.729 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' T' ' 55' ' ' GLY . . . 46.83 -163.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.93 0.395 . . . . 0.0 111.208 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -46.33 -18.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.839 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' T' ' 53' ' ' ALA . . . 146.38 33.99 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.87 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.421 ' HG2' ' OD1' ' T' ' 77' ' ' ASP . 1.3 ttm180 -86.37 135.1 33.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.658 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.4 m -116.66 138.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.44 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -160.18 161.98 32.89 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.12 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.709 ' HD2' HD11 ' T' ' 61' ' ' ILE . 4.3 p90 -143.94 87.29 8.11 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.78 0.324 . . . . 0.0 111.727 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 13.9 Cg_endo -58.61 117.75 4.52 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.594 2.196 . . . . 0.0 111.793 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.709 HD11 ' HD2' ' T' ' 59' ' ' TYR . 0.1 OUTLIER -115.16 117.07 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.688 -179.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' T' ' 45' ' ' HIS . 62.9 t -104.0 -30.41 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.15 93.64 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.579 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.67 158.37 42.3 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.38 -172.97 45.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.392 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.31 135.28 28.75 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.689 2.259 . . . . 0.0 112.295 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 55.05 28.8 11.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.08 -70.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.14 107.9 2.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.998 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.63 -4.56 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.84 -43.9 1.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.711 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -97.02 157.1 16.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 6.6 p -111.82 126.55 55.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.07 177.05 15.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.874 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.701 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.3 mt -59.66 117.9 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.401 . . . . 0.0 111.082 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.53 HG13 ' CD2' ' T' ' 59' ' ' TYR . 0.4 OUTLIER -95.61 89.26 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.836 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' T' ' 56' ' ' ARG . 2.5 t70 -127.25 126.17 42.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.18 19.26 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.417 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 60.79 175.29 1.33 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.889 HG22 ' H ' ' T' ' 82' ' ' LEU . 21.1 mm -46.76 126.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.23 23.81 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.889 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 57.58 16.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -163.72 106.31 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.563 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 9.0 ptt180 -83.14 32.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.62 7.49 30.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' T' ' 86' ' ' GLU . 5.7 mm-40 -59.89 171.17 0.98 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.725 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -114.49 82.43 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.707 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.697 ' O ' ' HB2' ' T' ' 14' ' ' LEU . 46.5 m95 -120.73 -160.7 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.856 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' T' ' 4' ' ' HIS . 21.8 m-20 -106.13 -142.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.148 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.79 120.78 3.52 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.682 ' OH ' HG13 ' T' ' 46' ' ' VAL . 4.5 m-85 -90.03 70.36 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.797 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -50.65 -178.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 111.873 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.851 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 40.5 t80 -163.94 150.9 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.692 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.997 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.9 m120 -171.23 118.93 0.46 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -11.37 14.96 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.46 2.107 . . . . 0.0 111.598 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -122.77 16.7 10.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.997 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -79.25 47.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.669 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -76.11 128.39 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.74 162.3 24.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 132.24 46.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.725 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 5' ' ' ARG . 6.6 mmt180 -143.83 160.36 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.831 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 1.0 OUTLIER -97.23 -169.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.985 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -66.02 -168.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.261 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -46.35 -38.87 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.418 ' H ' ' H ' ' T' ' 10' ' ' GLY . 0.6 OUTLIER -155.16 -14.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.2 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.418 ' H ' ' H ' ' T' ' 9' ' ' SER . . . -110.71 163.0 12.35 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.341 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 0.3 OUTLIER -113.83 152.74 30.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 49.47 61.98 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.144 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.923 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.3 OUTLIER -173.13 10.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.941 HD21 ' HA ' ' T' ' 89' ' ' ASP . 1.6 pp -99.77 170.38 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.647 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 29.4 p -117.22 -155.96 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.386 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 79.5 t80 -80.34 -57.95 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.037 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.53 69.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.056 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' T' ' 15' ' ' THR . 9.8 mt-10 -69.46 -64.3 0.9 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.776 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.771 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -40.13 -43.32 1.61 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.422 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.422 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 12.1 tttm -62.64 -51.04 68.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.011 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.55 83.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.66 -38.79 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 0.8 OUTLIER -68.19 -56.3 9.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -56.77 -22.37 35.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.234 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -90.92 -26.38 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.937 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -95.05 2.23 55.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' T' ' 97' ' ' ALA . . . 86.16 68.28 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.986 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' T' ' 94' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.561 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.5 ' HA ' ' HB3' ' T' ' 23' ' ' CYS . 0.0 OUTLIER -144.88 166.48 25.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.888 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.587 HD22 ' O ' ' T' ' 51' ' ' TRP . 15.7 mt -62.96 118.26 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -64.89 -165.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.124 0.488 . . . . 0.0 111.368 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.516 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.22 169.09 17.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.266 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.525 ' HD1' ' HE1' ' T' ' 52' ' ' MET . 23.3 t80 -57.29 -53.23 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -54.17 -48.12 71.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.516 ' CD ' HG23 ' T' ' 32' ' ' THR . 93.1 mt-30 -59.36 -34.76 72.79 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.716 ' HB3' HD11 ' T' ' 75' ' ' ILE . 0.5 OUTLIER -63.85 -33.51 75.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.065 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.22 -57.7 9.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.352 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -51.74 -31.11 25.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.226 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -72.37 -30.03 64.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.106 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -75.33 -36.8 60.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.623 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 17.4 mttt -51.41 -33.83 32.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.112 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.679 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.2 pt -84.8 -33.26 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.679 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.34 47.24 0.2 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.349 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.7 t80 -83.67 84.79 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.538 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 11.0 t-160 -94.66 117.55 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.055 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.57 HG23 ' H ' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -160.29 119.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.794 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -81.95 4.51 22.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.272 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.57 ' H ' HG23 ' T' ' 46' ' ' VAL . . . -91.18 87.47 6.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.782 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -41.96 135.65 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.186 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -116.35 128.27 7.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.948 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.587 ' O ' HD22 ' T' ' 30' ' ' LEU . 75.7 m95 -62.65 140.75 58.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.525 ' HE1' ' HD1' ' T' ' 33' ' ' TYR . 2.2 ptt? -137.83 -177.77 4.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.6 153.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.502 ' O ' HD12 ' T' ' 80' ' ' ILE . 6.6 mptt 67.38 -1.33 1.56 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 75.28 36.76 44.09 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.9 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.494 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 28.4 ttm180 -91.55 149.66 21.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.471 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -128.78 148.29 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -175.19 163.84 34.08 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.035 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.916 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.1 p90 -144.31 107.13 4.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 111.31 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 45.4 Cg_endo -71.04 106.77 1.96 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.615 2.21 . . . . 0.0 111.97 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.916 HD11 ' HD2' ' T' ' 59' ' ' TYR . 3.5 mm -99.54 113.94 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.387 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.493 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 61.7 t -95.84 -31.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.211 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.502 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -113.87 80.44 5.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.912 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' T' ' 73' ' ' THR . 49.8 Cg_endo -71.16 143.54 44.47 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.555 2.17 . . . . 0.0 112.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' T' ' 66' ' ' PRO . . . 178.3 -87.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.276 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' T' ' 65' ' ' GLY . 22.1 Cg_exo -64.81 -152.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -56.44 -9.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 64.6 m -84.41 -37.42 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.24 111.13 3.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.946 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.74 -15.79 23.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.87 -69.4 0.43 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.633 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -95.2 175.05 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . 0.404 HG22 ' HG3' ' T' ' 64' ' ' PRO . 47.1 p -112.12 131.86 55.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.82 177.36 15.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' T' ' 36' ' ' LEU . 5.3 mt -54.88 119.49 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.821 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -94.88 85.78 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -115.49 115.98 27.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.68 7.46 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.99 157.7 23.9 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.865 HG22 ' H ' ' T' ' 82' ' ' LEU . 1.3 mm -49.76 145.72 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.185 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' T' ' 81' ' ' ARG . 3.4 mmp_? -97.11 12.86 31.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.865 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 60.99 20.16 10.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 t-20 -168.68 111.16 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -73.13 26.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.487 ' H ' ' C ' ' T' ' 83' ' ' ASN . 40.1 t -92.4 -4.29 54.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.962 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' T' ' 86' ' ' GLU . 0.9 OUTLIER -64.15 164.53 10.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.789 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.7 mtm-85 -112.95 115.35 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.723 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 41.6 m95 -146.16 -150.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.693 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.941 ' HA ' HD21 ' T' ' 14' ' ' LEU . 1.8 m-20 -117.71 -144.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.764 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -162.36 123.84 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.921 0.391 . . . . 0.0 111.439 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.698 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 9.9 m-85 -88.44 73.46 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.68 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -47.17 161.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.768 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.5 OUTLIER -159.48 123.42 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.286 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.637 ' HB2' ' HA2' ' T' ' 28' ' ' GLY . 43.8 t-20 -166.26 117.48 0.8 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.34 5.05 1.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.533 2.155 . . . . 0.0 112.034 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.0 -8.31 8.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.531 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' T' ' 27' ' ' GLY . . . -80.05 54.33 1.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.61 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -82.78 129.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -127.69 164.35 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 138.89 33.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.975 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 30.9 mmt-85 -147.66 149.15 31.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -102.44 -168.63 1.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -89.19 163.81 15.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.89 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.51 72.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.497 ' HB3' ' CD ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -85.15 -15.94 42.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.995 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 146.25 169.35 14.07 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.322 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.816 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 2.1 tttt -75.7 146.91 39.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 111.272 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.521 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 2.8 m-30 62.92 75.98 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.231 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.781 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 1.3 ptpm? -179.63 -0.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.918 HD11 ' O ' ' T' ' 89' ' ' ASP . 1.3 pp -98.56 163.87 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.974 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.667 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 10.5 p -112.59 -156.09 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.282 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.1 t80 -77.79 -62.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.899 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.69 64.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.162 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' H ' ' T' ' 15' ' ' THR . 39.6 mt-10 -71.03 -58.0 3.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.765 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.688 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -45.07 -41.33 7.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.931 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' T' ' 30' ' ' LEU . 21.6 ttpt -62.31 -48.45 79.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.932 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.62 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.68 -40.65 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.391 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.456 ' HB3' ' HA ' ' T' ' 29' ' ' HIS . 1.1 m -71.13 -57.8 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.621 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.9 mt-10 -55.39 -11.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -91.85 -49.79 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 111.149 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.71 6.31 5.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.504 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.19 70.39 1.3 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.871 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.697 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . 165.34 -173.55 41.11 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -143.01 170.1 16.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.526 HD22 ' O ' ' T' ' 51' ' ' TRP . 14.7 mt -64.22 117.29 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.9 -166.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.078 0.466 . . . . 0.0 111.351 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.54 HG23 ' CD ' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.35 160.87 36.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.205 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.481 ' CE1' HG21 ' T' ' 75' ' ' ILE . 23.5 t80 -50.14 -52.69 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.68 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -53.19 -47.32 68.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.424 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.54 ' CD ' HG23 ' T' ' 32' ' ' THR . 30.4 mt-30 -59.38 -35.57 74.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.268 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -64.94 -31.53 72.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.998 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -63.59 -57.41 10.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.156 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HG3' ' T' ' 41' ' ' LYS . . . -52.36 -31.13 32.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.212 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -73.12 -30.42 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.225 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 40' ' ' ARG . 13.2 ttp85 -72.59 -35.84 68.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' T' ' 38' ' ' ALA . 29.9 mttt -51.17 -34.02 29.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.047 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.491 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.0 OUTLIER -87.18 -27.29 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.491 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 120.37 46.67 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.296 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.8 t80 -86.42 89.7 7.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 110.727 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.776 ' HD2' ' HA ' ' T' ' 61' ' ' ILE . 1.5 t-80 -109.12 110.72 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.401 ' HB ' ' OH ' ' T' ' 91' ' ' TYR . 0.8 OUTLIER -140.87 117.28 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.757 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -73.56 11.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.166 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' HE2' ' T' ' 11' ' ' LYS . . . -101.47 88.87 3.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.23 128.16 2.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' T' ' 91' ' ' TYR . . . -108.37 125.94 8.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.814 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 67.4 m95 -64.12 146.45 54.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.789 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' T' ' 56' ' ' ARG . 2.9 ptt? -150.37 -177.49 5.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.48 151.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.356 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.499 ' O ' HD12 ' T' ' 80' ' ' ILE . 2.1 mptp? 62.87 12.35 5.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 66.35 23.75 71.87 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.872 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' T' ' 52' ' ' MET . 37.2 ttm105 -74.1 140.95 45.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.691 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -130.75 144.25 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.325 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -167.78 161.25 35.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.114 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.931 ' HD2' HD11 ' T' ' 61' ' ' ILE . 2.8 p90 -143.61 103.0 4.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.835 0.35 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 32.6 Cg_endo -65.94 110.6 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.66 2.24 . . . . 0.0 111.89 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.931 HD11 ' HD2' ' T' ' 59' ' ' TYR . 7.2 mm -103.39 96.23 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.496 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.54 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 47.9 t -90.95 -31.3 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.832 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -116.88 91.03 34.26 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.511 ' HB3' ' HA3' ' T' ' 69' ' ' GLY . 18.8 Cg_endo -61.61 168.61 8.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.54 2.16 . . . . 0.0 112.311 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.57 -164.28 24.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.149 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.437 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 72.0 Cg_endo -75.1 8.74 2.32 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.48 2.12 . . . . 0.0 112.447 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.437 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 4.3 p30 177.63 61.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.86 -58.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.763 ' HA2' HG21 ' T' ' 61' ' ' ILE . . . -74.74 117.22 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.961 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -79.63 3.02 20.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.61 -60.98 0.67 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.626 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.56 174.09 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.838 0.351 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 71.5 p -116.98 121.22 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 173.31 21.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.033 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.8 mt -58.73 118.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.591 HG13 HG12 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -91.33 85.31 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.411 ' OD2' ' HG2' ' T' ' 56' ' ' ARG . 4.6 t0 -114.98 113.61 24.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.027 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.95 16.63 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.72 174.58 25.96 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.706 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.7 mm -56.23 151.38 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' T' ' 86' ' ' GLU . 1.1 mmt180 -100.46 12.61 36.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.662 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.706 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.3 OUTLIER 61.04 22.73 12.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.933 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -172.95 114.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.135 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -76.86 48.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -124.12 -1.14 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' T' ' 81' ' ' ARG . 7.1 mm-40 -65.55 160.41 22.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.781 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 0.0 OUTLIER -103.8 125.2 50.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 29.9 m95 -157.9 -152.62 0.35 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.918 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.4 m-20 -118.12 -146.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.708 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -164.77 128.1 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 111.639 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.536 ' CG ' HD21 ' T' ' 36' ' ' LEU . 10.1 m-85 -92.07 74.71 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.588 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.643 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.8 OUTLIER -47.77 157.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.397 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 1.1 t80 -153.21 130.17 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.241 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.697 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 0.9 OUTLIER -170.0 118.93 0.54 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -2.61 7.2 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.394 2.063 . . . . 0.0 111.794 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -117.54 -11.14 10.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.766 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.9 53.97 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.657 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -78.8 126.92 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 111.137 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -123.19 164.17 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 144.72 25.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 29.7 mmt-85 -141.65 166.23 25.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' T' ' 11' ' ' LYS . 6.0 mp0 -107.99 -176.75 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' T' ' 14' ' ' LEU . . . -66.27 -169.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -26.33 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.7 t -172.38 47.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' T' ' 6' ' ' GLU . . . 174.63 166.6 32.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.387 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.51 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 2.3 ttpt -103.37 143.81 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.007 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.4 ' CZ ' ' HZ3' ' T' ' 88' ' ' TRP . 3.6 m-30 56.24 69.61 0.72 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.045 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -174.26 3.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.834 ' CD1' ' HB2' ' T' ' 19' ' ' ALA . 3.1 pp -96.75 167.37 11.15 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.716 0.293 . . . . 0.0 110.969 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.615 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 16.3 p -117.7 -155.33 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' T' ' 84' ' ' ARG . 76.4 t80 -80.68 -58.77 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.198 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.65 70.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.13 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' T' ' 15' ' ' THR . 17.6 mt-10 -68.37 -63.81 0.99 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.455 0.645 . . . . 0.0 109.59 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -42.07 -46.65 4.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.219 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -59.41 -43.76 92.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -48.63 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.46 -37.82 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.334 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.94 -60.29 2.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.492 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.0 tt0 -58.29 -8.15 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -81.16 -31.62 34.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.217 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.81 -3.53 54.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.741 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . 0.414 ' O ' ' ND2' ' T' ' 94' ' ' ASN . . . 101.37 17.34 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.078 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -128.53 -165.2 11.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.735 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 177.04 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.478 HD22 ' O ' ' T' ' 51' ' ' TRP . 36.4 mt -68.61 118.71 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -61.79 -166.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 111.438 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.596 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -133.7 171.33 14.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.133 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' T' ' 75' ' ' ILE . 27.6 t80 -58.96 -54.58 45.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.738 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -53.11 -47.77 68.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.443 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.596 ' OE1' HG23 ' T' ' 32' ' ' THR . 94.3 mt-30 -60.98 -35.97 78.21 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.294 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.602 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -66.83 -27.72 67.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.752 179.124 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 22.1 tt0 -64.19 -58.77 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.233 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.25 -31.8 54.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.934 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.65 -33.76 76.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.534 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.449 ' NH1' ' H ' ' T' ' 75' ' ' ILE . 47.4 ttp180 -80.33 -35.15 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.657 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -51.01 -29.54 12.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.852 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.543 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.1 pp -92.38 -32.64 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.01 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.543 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.98 47.67 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.691 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.0 OUTLIER -83.37 85.98 7.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' T' ' 63' ' ' LYS . 17.0 t-160 -92.52 123.06 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.527 HG13 ' OH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -172.19 114.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.762 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.537 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.0 OUTLIER -77.05 2.53 14.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.455 ' H ' ' CG2' ' T' ' 46' ' ' VAL . . . -90.46 88.2 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.843 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.858 ' HB2' ' HD1' ' T' ' 59' ' ' TYR . . . -44.48 134.21 5.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.84 126.3 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.655 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 92.2 m95 -57.41 150.73 17.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . . . . . . . . . 1.6 ptp -148.47 -170.37 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -50.9 150.71 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.9 -12.68 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' T' ' 53' ' ' ALA . . . 87.71 32.39 13.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.686 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -88.01 147.35 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.693 HG21 ' NE1' ' T' ' 88' ' ' TRP . 0.9 OUTLIER -125.81 144.98 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.277 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -173.56 163.39 34.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.136 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.858 ' HD1' ' HB2' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -138.23 102.58 8.15 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 111.292 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 14.5 Cg_exo -66.67 92.74 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.885 2.39 . . . . 0.0 111.887 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.937 HG12 HG13 ' T' ' 76' ' ' ILE . 4.7 mm -88.09 116.19 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.378 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.445 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 2.2 t -92.48 -31.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -119.9 95.06 49.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.713 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.7 Cg_exo -51.71 154.91 8.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.616 2.211 . . . . 0.0 112.377 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.81 -174.3 46.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.396 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.23 138.16 38.81 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.209 . . . . 0.0 112.252 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 57.38 20.99 6.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 11.0 t -144.38 43.88 1.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.0 155.15 18.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.923 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -76.05 -3.29 35.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.347 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 119.48 21.3 3.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.71 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -100.72 156.64 17.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 43.5 p -114.82 119.9 38.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.45 172.39 12.57 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.012 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.753 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 5.0 mt -56.93 116.92 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 0.0 110.971 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.937 HG13 HG12 ' T' ' 61' ' ' ILE . 0.7 OUTLIER -95.2 87.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.993 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 0.0 OUTLIER -127.64 137.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.964 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -104.3 22.48 14.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 62.56 168.29 0.8 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.769 HG22 ' H ' ' T' ' 82' ' ' LEU . 5.1 mm -47.29 136.8 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.1 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 81' ' ' ARG . 0.6 OUTLIER -100.73 24.93 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.769 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 55.84 21.07 4.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.969 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.556 HD21 ' HB2' ' T' ' 85' ' ' SER . 39.5 t30 -161.82 97.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -80.47 32.06 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.556 ' HB2' HD21 ' T' ' 83' ' ' ASN . 5.2 m -110.87 5.94 20.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.412 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 1.2 mm-40 -62.99 166.73 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.856 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 6.0 mtt180 -105.45 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.304 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.777 ' CE3' ' HB3' ' T' ' 49' ' ' ALA . 40.8 m95 -135.54 -151.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.786 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.831 ' O ' HD11 ' T' ' 14' ' ' LEU . 1.1 m-20 -112.53 -149.4 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.458 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' T' ' 89' ' ' ASP . . . -158.52 118.25 3.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.582 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 6.9 m-85 -87.89 73.59 9.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.945 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.496 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 3.3 m -51.69 160.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.477 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HB2' ' HB2' ' T' ' 31' ' ' ALA . 0.6 OUTLIER -153.49 120.25 5.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.261 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' T' ' 97' ' ' ALA . 30.1 t30 -166.31 111.63 0.72 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.645 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 38.2 Cg_endo -66.65 6.43 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.665 2.243 . . . . 0.0 112.268 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' T' ' 94' ' ' ASN . 0.3 OUTLIER -133.49 6.9 3.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.798 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' T' ' 94' ' ' ASN . . . -82.88 51.49 1.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.959 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -84.96 125.89 40.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.348 . . . . 0.0 111.351 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.689 ' CE1' ' HB3' ' T' ' 92' ' ' CYS . 0.1 OUTLIER -124.47 157.05 36.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.768 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.647 ' HB2' ' CE1' ' T' ' 91' ' ' TYR . 36.7 t60 -103.45 104.58 14.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.179 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.21 164.73 12.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.98 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.685 ' HB2' ' HA ' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -107.78 -167.16 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' T' ' 14' ' ' LEU . . . -93.69 153.29 18.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.972 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -21.19 66.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -88.1 -16.6 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.51 168.4 15.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.349 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.685 ' HA ' ' HB2' ' T' ' 6' ' ' GLU . 1.7 ttpm? -92.73 147.54 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 0.4 OUTLIER 60.01 56.43 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.776 ' HA ' ' HB2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -168.86 8.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.381 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' T' ' 89' ' ' ASP . 4.1 pp -97.34 170.78 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.772 0.32 . . . . 0.0 110.777 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.687 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 15.8 p -118.06 -156.4 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.382 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' T' ' 84' ' ' ARG . 88.3 t80 -80.76 -51.93 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.954 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.24 72.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.977 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.687 ' HB2' ' H ' ' T' ' 15' ' ' THR . 28.8 mt-10 -74.54 -59.34 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.876 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -46.92 -45.3 20.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.82 -48.61 81.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.88 -43.63 90.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' T' ' 7' ' ' ALA . 1.4 t -54.91 -39.25 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.157 0.504 . . . . 0.0 110.332 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.82 -60.26 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.611 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.3 mt-10 -55.25 -8.89 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -80.47 -39.9 27.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.986 0.422 . . . . 0.0 110.186 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.52 -8.0 59.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.16 22.23 8.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.069 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.604 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -135.39 -163.47 10.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.747 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -148.93 172.4 14.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.912 0.387 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.516 HD13 ' O ' ' T' ' 51' ' ' TRP . 58.1 mt -65.84 125.49 25.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.567 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' T' ' 93' ' ' TYR . . . -59.06 -167.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.453 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.589 HG23 ' OE1' ' T' ' 35' ' ' GLN . 0.1 OUTLIER -130.42 166.63 20.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.22 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.444 ' CE1' HG21 ' T' ' 75' ' ' ILE . 21.0 t80 -55.69 -53.85 51.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 9.7 mttt -53.9 -47.63 70.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.54 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.589 ' OE1' HG23 ' T' ' 32' ' ' THR . 93.3 mt-30 -60.76 -34.49 74.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.489 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.615 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -67.22 -28.62 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.832 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 28.7 tp10 -64.69 -59.37 4.33 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.203 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -31.93 58.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.971 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -65.34 -33.58 76.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.551 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.411 ' HA ' ' H ' ' T' ' 44' ' ' PHE . 68.0 ttp85 -80.77 -35.79 32.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.646 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -51.59 -30.48 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.62 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.62 HG13 ' N ' ' T' ' 43' ' ' GLY . 1.3 pt -90.86 -32.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.62 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.69 48.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.613 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 1.3 t80 -91.93 83.93 5.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' T' ' 62' ' ' VAL . 10.8 t-160 -93.73 135.87 34.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.803 HG22 ' H ' ' T' ' 48' ' ' ALA . 1.3 p -179.6 113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.651 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.08 13.29 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.803 ' H ' HG22 ' T' ' 46' ' ' VAL . . . -100.3 124.4 45.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -77.62 131.54 37.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.7 125.57 7.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.646 ' NE1' ' HB2' ' T' ' 88' ' ' TRP . 86.4 m95 -64.11 115.74 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.819 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.449 ' HA ' ' HB3' ' T' ' 30' ' ' LEU . 4.7 ptt? -136.44 178.49 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.21 -163.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.222 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.27 -23.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.463 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 150.34 36.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.907 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm105 -91.17 142.97 27.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.672 0.272 . . . . 0.0 110.79 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.47 HG21 ' NE1' ' T' ' 88' ' ' TRP . 1.1 m -121.36 153.96 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . 178.6 163.94 30.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.211 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.849 ' HD2' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -137.25 95.99 11.43 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.754 0.311 . . . . 0.0 111.345 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' OH ' ' T' ' 91' ' ' TYR . 18.1 Cg_endo -61.36 98.68 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.604 2.203 . . . . 0.0 111.866 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.849 HD11 ' HD2' ' T' ' 59' ' ' TYR . 4.6 mm -91.54 141.38 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.588 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.573 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 3.2 t -134.75 -19.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.758 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -128.64 63.8 66.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.753 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' T' ' 62' ' ' VAL . 47.9 Cg_exo -54.38 145.84 54.54 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.665 2.244 . . . . 0.0 112.546 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.79 -98.91 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.141 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' T' ' 67' ' ' ASN . 64.6 Cg_endo -73.83 -144.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.583 2.188 . . . . 0.0 111.973 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' T' ' 66' ' ' PRO . 0.6 OUTLIER -50.02 -22.72 1.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' T' ' 47' ' ' CYS . 99.7 m -93.59 96.48 9.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.854 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.87 105.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.036 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' T' ' 76' ' ' ILE . 0.5 OUTLIER -76.17 0.12 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.99 -34.1 5.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.615 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -100.01 170.1 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 18.3 p -110.86 121.12 44.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.69 178.61 27.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 6.8 mt -69.6 119.83 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.02 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' T' ' 58' ' ' GLY . 0.7 OUTLIER -90.52 86.77 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.979 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.2 112.68 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.093 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -84.25 13.34 5.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.31 168.48 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.936 HG22 ' H ' ' T' ' 82' ' ' LEU . 6.2 mm -45.73 128.63 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -87.22 25.39 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.018 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.936 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.9 OUTLIER 57.11 15.96 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.678 HD21 ' HB3' ' T' ' 85' ' ' SER . 40.3 t30 -163.55 110.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.632 ' HD3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -84.55 34.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.678 ' HB3' HD21 ' T' ' 83' ' ' ASN . 34.7 t -117.55 11.56 13.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' HZ2' ' T' ' 51' ' ' TRP . 34.9 mm-40 -70.75 159.8 33.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.776 ' HB2' ' HA ' ' T' ' 13' ' ' LYS . 7.5 ptp180 -93.12 120.26 33.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.785 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 22.4 m95 -155.77 -148.37 0.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.471 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.872 ' HA ' HD21 ' T' ' 14' ' ' LEU . 29.9 m-20 -126.0 -141.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.536 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -167.78 126.36 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.868 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.684 ' OH ' ' HD2' ' T' ' 60' ' ' PRO . 19.0 m-85 -85.76 71.58 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.689 ' HB3' ' CE1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -44.16 159.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 25.0 t80 -150.27 140.8 22.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 1.063 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.6 m120 -163.41 117.79 1.11 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.808 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -55.27 -13.07 6.46 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.511 2.141 . . . . 0.0 111.475 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -126.03 24.4 6.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.594 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 1.063 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -81.78 48.31 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 tttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.962 179.96 . . . . . . . . 0 0 . 1 stop_ save_